这是一篇来自已证抗体库的有关小鼠 Il2ra的综述,是根据418篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Il2ra 抗体。
Il2ra 同义词: CD25; Il2r; Ly-43

赛默飞世尔
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 6a
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 6a). Sci Adv (2020) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s2d
赛默飞世尔 Il2ra抗体(eBioscience, 53-0251-82)被用于被用于流式细胞仪在小鼠样本上 (图 s2d). Cell (2019) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s7a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5.)被用于被用于流式细胞仪在小鼠样本上 (图 s7a). Sci Adv (2019) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2c
赛默飞世尔 Il2ra抗体(Thermo Fisher, 47-0251-82)被用于被用于流式细胞仪在小鼠样本上 (图 2c). Cell Rep (2019) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 3e
赛默飞世尔 Il2ra抗体(eBioscience, 17-0251-82)被用于被用于流式细胞仪在小鼠样本上 (图 3e). Nature (2019) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1g
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1g). J Clin Invest (2019) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1e
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1e). J Exp Med (2019) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2c
赛默飞世尔 Il2ra抗体(Thermo Fisher Scientific, 53-0251-82)被用于被用于流式细胞仪在小鼠样本上 (图 2c). J Clin Invest (2019) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 8a
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 8a). Nat Commun (2018) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 1:300; 图 1a
赛默飞世尔 Il2ra抗体(eBiosciences, PC61)被用于被用于流式细胞仪在小鼠样本上浓度为1:300 (图 1a). Nat Commun (2018) ncbi
大鼠 单克隆(eBio7D4 (7D4))
  • 流式细胞仪; 小鼠; 图 3c, 4d
赛默飞世尔 Il2ra抗体(eBioscience, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 3c, 4d). Proc Natl Acad Sci U S A (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1c
赛默飞世尔 Il2ra抗体(eBioscience, 17-02510-81)被用于被用于流式细胞仪在小鼠样本上 (图 1c). Nat Commun (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s7b
赛默飞世尔 Il2ra抗体(eBioscience, 12-0251-81)被用于被用于流式细胞仪在小鼠样本上 (图 s7b). Nat Commun (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4e
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 4e). Front Immunol (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4c
赛默飞世尔 Il2ra抗体(Thermo Fisher Scientific, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 4c). Eur J Immunol (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:100; 图 4c
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 4c). Infect Immun (2018) ncbi
大鼠 单克隆(eBio7D4 (7D4))
  • 流式细胞仪; 小鼠; 1:6; 图 s2c
赛默飞世尔 Il2ra抗体(ThermoFisher, 7D4)被用于被用于流式细胞仪在小鼠样本上浓度为1:6 (图 s2c). PLoS Pathog (2018) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 1h
赛默飞世尔 Il2ra抗体(ebioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1h). Nat Commun (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4b
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 4b). J Immunol (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1c
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1c). J Immunol (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:1000; 图 2f
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:1000 (图 2f). J Immunol (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s2c
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s2c). J Immunol (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 6f
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 6f). J Exp Med (2018) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 9c
赛默飞世尔 Il2ra抗体(Invitrogen, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 9c). J Immunol (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2a
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2a). J Cell Biol (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 5b
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 5b). Int J Biochem Cell Biol (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 5a
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 5a). J Immunol (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 3e
赛默飞世尔 Il2ra抗体(eBioscience, 17-0251)被用于被用于流式细胞仪在小鼠样本上 (图 3e). Nature (2017) ncbi
大鼠 单克隆(eBio7D4 (7D4))
  • 流式细胞仪; 仓鼠; 图 s1a
赛默飞世尔 Il2ra抗体(eBioscience, 7D4)被用于被用于流式细胞仪在仓鼠样本上 (图 s1a). Immunology (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2d
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2d). Stem Cells (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 3a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 3a). Immunology (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Sci Rep (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. Science (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Int J Parasitol (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1a
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1a). J Clin Invest (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:100; 图 1a
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 1a). Nat Immunol (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1,3
赛默飞世尔 Il2ra抗体(eBioscience, 17-0251-82)被用于被用于流式细胞仪在小鼠样本上 (图 1,3). Oncoimmunology (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 7b
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 7b). J Immunol (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2b
赛默飞世尔 Il2ra抗体(eBioscience, 12-0251)被用于被用于流式细胞仪在小鼠样本上 (图 2b). Sci Rep (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2a). elife (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2). Proc Natl Acad Sci U S A (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. J Biol Chem (2017) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 s2b
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s2b). PLoS ONE (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. Cell Death Dis (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 7a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 7a). J Immunol (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4d
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 4d). Nature (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s2e
赛默飞世尔 Il2ra抗体(eBioscience, PC 61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s2e). J Clin Invest (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2b
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2b). Circ Res (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:800; 图 5
赛默飞世尔 Il2ra抗体(eBioscience, 12-0251-81)被用于被用于流式细胞仪在小鼠样本上浓度为1:800 (图 5). Exp Ther Med (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2c
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2c). J Exp Med (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2e
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2e). J Exp Med (2016) ncbi
大鼠 单克隆(eBio3C7 (3C7))
  • 流式细胞仪; 小鼠; 图 3c
赛默飞世尔 Il2ra抗体(eBioscience, 3C7)被用于被用于流式细胞仪在小鼠样本上 (图 3c). J Clin Invest (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:100; 图 4
赛默飞世尔 Il2ra抗体(eBiosciences, 45-0251-82)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 4). Nat Commun (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s1
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s1). PLoS ONE (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s1a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s1a). J Clin Invest (2016) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 2a
赛默飞世尔 Il2ra抗体(BD Pharmingen or eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2a). Mol Cell Biol (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1b
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1b). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Il2ra抗体(eBioscience, 25-0251-81)被用于被用于流式细胞仪在小鼠样本上 (图 4). Sci Rep (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 5c
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 5c). J Neuroimmunol (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1-s1
赛默飞世尔 Il2ra抗体(eBiosciences, 36-0251-85)被用于被用于流式细胞仪在小鼠样本上 (图 1-s1). elife (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:200; 图 1
赛默飞世尔 Il2ra抗体(eBioscience, 25-0251-82)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 1). Nat Immunol (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:250; 图 st1
赛默飞世尔 Il2ra抗体(eBioscience, 25-0251)被用于被用于流式细胞仪在小鼠样本上浓度为1:250 (图 st1). Nat Commun (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, 17-0251-81)被用于被用于流式细胞仪在小鼠样本上. J Allergy Clin Immunol (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s1c
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s1c). J Allergy Clin Immunol (2017) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Il2ra抗体(eBioscience, 45-0251)被用于被用于流式细胞仪在小鼠样本上 (图 3). Mol Med Rep (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2). J Clin Invest (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s3b
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s3b). Science (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s1a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s1a). J Allergy Clin Immunol (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, 17-0251)被用于被用于流式细胞仪在小鼠样本上. Biol Open (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Science (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:200; 图 S2c
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 S2c). Nat Commun (2016) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 2b
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2b). PLoS ONE (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, 25-0251-82)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 4). PLoS ONE (2016) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 6s
赛默飞世尔 Il2ra抗体(Invitrogen, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 6s). J Immunol (2016) ncbi
大鼠 单克隆(PC61.5)
  • 抑制或激活实验; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于抑制或激活实验在小鼠样本上 (图 1). Dis Model Mech (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1d
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1d). Arthritis Rheumatol (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 3b
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 3b). Nat Commun (2015) ncbi
大鼠 单克隆(PC61.5)
  • 免疫细胞化学; 小鼠; 图 2a
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于免疫细胞化学在小鼠样本上 (图 2a). Sci Rep (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Il2ra抗体(eBioscience, 12-0251)被用于被用于流式细胞仪在小鼠样本上 (图 4). Nat Neurosci (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. Nat Genet (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Il2ra抗体(eBioscience, 47-0251-80)被用于被用于流式细胞仪在小鼠样本上 (图 4). Aging Cell (2016) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s7
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s7). Mucosal Immunol (2016) ncbi
大鼠 单克隆(PC61.5.3)
  • 免疫组化; 小鼠; 图 3a
赛默飞世尔 Il2ra抗体(Invitrogen, PC61 5.3)被用于被用于免疫组化在小鼠样本上 (图 3a). J Exp Med (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2). Nat Immunol (2015) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Invitrogen, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. Infect Immun (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(eBioscience, 17-0251)被用于被用于流式细胞仪在小鼠样本上 (图 2). Int J Obes (Lond) (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1). PLoS ONE (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:500; 图 4
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:500 (图 4). Nat Commun (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 6b
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 6b). Transplantation (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4e
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 4e). Sci Transl Med (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s2
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s2). Nat Immunol (2015) ncbi
大鼠 单克隆(PC61.5)
  • 免疫印迹; 小鼠; 1:100; 图 5,6
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5.3)被用于被用于免疫印迹在小鼠样本上浓度为1:100 (图 5,6). Nat Commun (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. Cancer Immunol Res (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s2
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s2). PLoS Pathog (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. Immunology (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 表 1
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (表 1). J Neuroinflammation (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s5
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s5). Nat Immunol (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1e
赛默飞世尔 Il2ra抗体(ebioscience, 48-0251-82)被用于被用于流式细胞仪在小鼠样本上 (图 1e). Nat Commun (2014) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag Burlingham, clone PC61.5.3)被用于被用于流式细胞仪在小鼠样本上. Immunobiology (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:1000
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:1000. Cytokine (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4). Immunol Lett (2015) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. elife (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:100
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. PLoS ONE (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, 85-15-0251-81)被用于被用于流式细胞仪在小鼠样本上. J Mol Cell Cardiol (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2). PLoS ONE (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1). Nat Immunol (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 1:100
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. Nat Commun (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2013) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. Diabetes (2014) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 3). PLoS ONE (2013) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 5a
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 5a). Nat Methods (2013) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 5
赛默飞世尔 Il2ra抗体(Invitrogen, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 5). Eur J Immunol (2013) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上. FASEB J (2013) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag Laboratories, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2012) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2012) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, 12-0251-82)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2011) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Il2ra抗体(eBiosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 3). PLoS ONE (2011) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1). PLoS ONE (2011) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, clone PC61.5)被用于被用于流式细胞仪在小鼠样本上. Brain Behav Immun (2011) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 表 1
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (表 1). Infect Immun (2010) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 4). Clin Exp Allergy (2010) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 7
赛默飞世尔 Il2ra抗体(CalTag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 7). J Immunol (2009) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上. Int Immunol (2009) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 5
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5). Clin Exp Immunol (2009) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上. Cell Res (2008) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 Il2ra抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 1). Clin Exp Immunol (2008) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 3). J Immunol (2008) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. Immunology (2008) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. Parasite Immunol (2007) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 7B
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 7B). J Immunol (2007) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2). Cancer Res (2007) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 1). Blood (2007) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(E-Bioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. J Biomed Mater Res A (2007) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Il2ra抗体(ebiosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4). Int Immunopharmacol (2006) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. Nat Immunol (2007) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1). Blood (2007) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(Caltag, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1). Infect Immun (2007) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 2A
赛默飞世尔 Il2ra抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 2A). FASEB J (2006) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2006) ncbi
大鼠 单克隆(PC61.5.3)
  • 免疫组化-石蜡切片; 小鼠; 图 5
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5). Am J Pathol (2006) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上. Proc Natl Acad Sci U S A (2006) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2006) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2006) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(ebiosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. Cytometry A (2006) ncbi
大鼠 单克隆(PC61.5.3)
  • 其他; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于其他在小鼠样本上. J Immunol (2006) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 Il2ra抗体(Caltag, 3G10)被用于被用于流式细胞仪在人类样本上 (图 5). Biochem Biophys Res Commun (2005) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(eBioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1). J Immunol (2005) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(Caltag, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1). J Immunol (2005) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61-5.3)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2005) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61)被用于被用于流式细胞仪在小鼠样本上. J Cell Sci (2005) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. J Virol (2005) ncbi
大鼠 单克隆(PC61.5)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(eBioscience, PC61)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2004) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 3). J Immunol (2004) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC 61 5.3)被用于被用于流式细胞仪在小鼠样本上. Am J Transplant (2004) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61-5.3)被用于被用于流式细胞仪在小鼠样本上. J Virol (2003) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 4). Int Immunol (2003) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(Caltag, PC61.5.3)被用于被用于流式细胞仪在小鼠样本上 (图 2). J Immunol (2003) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 表 1
赛默飞世尔 Il2ra抗体(Caltag, PC61)被用于被用于流式细胞仪在小鼠样本上 (表 1). Eur J Immunol (2003) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Il2ra抗体(Caltag, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4). J Immunol (2003) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(Caltag, PC61.5.3)被用于被用于流式细胞仪在小鼠样本上 (图 2). J Immunol (2002) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. Cell Immunol (2002) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 8
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 8). Int Immunol (2002) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 4, 5
赛默飞世尔 Il2ra抗体(CALTAG, PC61.5.3)被用于被用于流式细胞仪在小鼠样本上 (图 4, 5). J Immunol (2002) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 8
赛默飞世尔 Il2ra抗体(Caltag Laboratories, PC61.5.3)被用于被用于流式细胞仪在小鼠样本上 (图 8). J Immunol (2001) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 Il2ra抗体(Caltag, 3G10)被用于被用于流式细胞仪在人类样本上 (图 1a). Blood (2001) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2001) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. J Clin Invest (2001) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 Il2ra抗体(CalTag, PC61.5.3)被用于被用于流式细胞仪在小鼠样本上 (图 1). J Immunol (2001) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, clone PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. Nat Immunol (2001) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 Il2ra抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 4). Int Immunol (2001) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(Caltag, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2). Eur J Immunol (2001) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 3). Int Immunol (2001) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 Il2ra抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上. Infect Immun (2000) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61.5.3)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (1999) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61.5.3.)被用于被用于流式细胞仪在小鼠样本上. Proc Natl Acad Sci U S A (1999) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. J Immunol (1999) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. Blood (1999) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 2, 3
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (图 2, 3). J Immunol (1999) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上. J Immunol (1998) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 Il2ra抗体(BioSource, CD25-3g10)被用于被用于流式细胞仪在人类样本上. J Immunol (1998) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC 61 5.3)被用于被用于流式细胞仪在小鼠样本上. Int Immunol (1998) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (1998) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Il2ra抗体(Caltag, PC61.5.3)被用于被用于流式细胞仪在小鼠样本上. Blood (1997) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(Caltag Laboratories, clone PC61.5.3)被用于被用于流式细胞仪在小鼠样本上 (图 2). Blood (1997) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 表 1
赛默飞世尔 Il2ra抗体(Caltag, PC61 5.3)被用于被用于流式细胞仪在小鼠样本上 (表 1). Int Immunol (1997) ncbi
大鼠 单克隆(PC61.5.3)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Il2ra抗体(noco, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2). Nature (1985) ncbi
大鼠 单克隆(PC61.5.3)
  • 其他; 小鼠; 图 1
  • 免疫组化-冰冻切片; 小鼠; 图 3
赛默飞世尔 Il2ra抗体(noco, PC61)被用于被用于其他在小鼠样本上 (图 1) 和 被用于免疫组化-冰冻切片在小鼠样本上 (图 3). Nature (1985) ncbi
BioLegend
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 1:100; 图 3a, 3b
BioLegend Il2ra抗体(Biolegend, 101913)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 3a, 3b). Nat Commun (2020) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 6c, s6b
BioLegend Il2ra抗体(Biolegend, 101909)被用于被用于流式细胞仪在小鼠样本上 (图 6c, s6b). Nat Commun (2020) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 s1c
BioLegend Il2ra抗体(BioLegend, 101913)被用于被用于流式细胞仪在小鼠样本上 (图 s1c). Cell (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 6d
BioLegend Il2ra抗体(Biolegend, 102033)被用于被用于流式细胞仪在小鼠样本上 (图 6d). Cell (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s6a
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s6a). Science (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1a
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Nat Med (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4a
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4a). J Exp Med (2019) ncbi
小鼠 单克隆(OX-39)
  • 流式细胞仪; 大鼠; 图 s1c
BioLegend Il2ra抗体(Biolegend, OX-39)被用于被用于流式细胞仪在大鼠样本上 (图 s1c). Nature (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4f
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4f). Nature (2019) ncbi
大鼠 单克隆(PC61)
  • mass cytometry; 小鼠; 图 5c
BioLegend Il2ra抗体(Biolegend, 102002)被用于被用于mass cytometry在小鼠样本上 (图 5c). Cell (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1e
BioLegend Il2ra抗体(Biolegend, 102008)被用于被用于流式细胞仪在小鼠样本上 (图 1e). Cell Rep (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3a
BioLegend Il2ra抗体(Biolegend, 102024)被用于被用于流式细胞仪在小鼠样本上 (图 3a). Nat Commun (2018) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 4a
BioLegend Il2ra抗体(BioLegend, 101904)被用于被用于流式细胞仪在小鼠样本上 (图 4a). J Cyst Fibros (2019) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 2.5 ug/ml; 图 s4
BioLegend Il2ra抗体(Biolegend, 101915)被用于被用于流式细胞仪在小鼠样本上浓度为2.5 ug/ml (图 s4). Nat Commun (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s6a
BioLegend Il2ra抗体(BioLegend, 102035)被用于被用于流式细胞仪在小鼠样本上 (图 s6a). Immunity (2018) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 6b
BioLegend Il2ra抗体(Biolegend, 101918)被用于被用于流式细胞仪在小鼠样本上 (图 6b). J Clin Invest (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4a
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4a). Front Immunol (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s13b
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s13b). Science (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:300; 图 s1a
BioLegend Il2ra抗体(BioLegend, 102012)被用于被用于流式细胞仪在小鼠样本上浓度为1:300 (图 s1a). PLoS Biol (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:200; 图 s4a
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 s4a). Nat Commun (2018) ncbi
大鼠 单克隆(PC61)
BioLegend Il2ra抗体(BioLegend, PC61)被用于. Mol Biol Cell (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3h
BioLegend Il2ra抗体(Biolegend, 102036)被用于被用于流式细胞仪在小鼠样本上 (图 3h). Science (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 8
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 8). J Immunol (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:100; 图 s1a
BioLegend Il2ra抗体(BioLegend, 102008)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s1a). Nat Commun (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5b
BioLegend Il2ra抗体(Biolegend, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 5b). Eur J Immunol (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1j
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1j). J Exp Med (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上. Science (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1a
BioLegend Il2ra抗体(BioLegend, 102033)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Immunity (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1a
BioLegend Il2ra抗体(BioLegend, PL61)被用于被用于流式细胞仪在小鼠样本上 (图 1a). J Exp Med (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上. Proc Natl Acad Sci U S A (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3a
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3a). J Exp Med (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4b
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4b). Front Immunol (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上. Proc Natl Acad Sci U S A (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s6a
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s6a). Nature (2017) ncbi
大鼠 单克隆(7D4/CD25)
  • 流式细胞仪; 小鼠; 图 7e
BioLegend Il2ra抗体(BioLegend, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 7e). J Exp Med (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2c
BioLegend Il2ra抗体(BD, 102012)被用于被用于流式细胞仪在小鼠样本上 (图 2c). J Exp Med (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 6i
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 6i). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 人类; 图 5
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在人类样本上 (图 5). Nature (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 6c
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 6c). Mol Ther (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2c
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2c). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s1
BioLegend Il2ra抗体(BioLegend, 102020)被用于被用于流式细胞仪在小鼠样本上 (图 s1). PLoS ONE (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1a
BioLegend Il2ra抗体(BioLegend, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1a). J Exp Med (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s6c
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s6c). J Clin Invest (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s6
BioLegend Il2ra抗体(BioLegend, 102030)被用于被用于流式细胞仪在小鼠样本上 (图 s6). Cell (2016) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 3
BioLegend Il2ra抗体(BioLegend, 101908)被用于被用于流式细胞仪在小鼠样本上 (图 3). Exp Ther Med (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1a
BioLegend Il2ra抗体(Biolegend, 102029)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Nat Commun (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5a
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5a). J Exp Med (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:200; 图 4
BioLegend Il2ra抗体(eBioscience, 102008)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 4). Nat Commun (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5d
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5d). Antimicrob Agents Chemother (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s4
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s4). Sci Rep (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5). Clin Cancer Res (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s3
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s3). J Clin Invest (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5c
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5c). J Neuroimmunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2e
BioLegend Il2ra抗体(BioLegend, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 2e). J Exp Med (2016) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 s2c
BioLegend Il2ra抗体(Biolegend, 101910)被用于被用于流式细胞仪在小鼠样本上 (图 s2c). Eur J Immunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 人类; 图 2
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在人类样本上 (图 2). J Clin Invest (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 6
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 6). Oncotarget (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3d
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3d). PLoS ONE (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:200; 图 s1
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 s1). Nat Commun (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2016) ncbi
大鼠 单克隆(7D4/CD25)
  • 流式细胞仪; 小鼠; 图 2a
BioLegend Il2ra抗体(BioLegend, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 2a). Cell Biosci (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:100; 图 s5
BioLegend Il2ra抗体(Biolegend, PC61.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s5). Nat Commun (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s2
BioLegend Il2ra抗体(Biolegend, 102008)被用于被用于流式细胞仪在小鼠样本上 (图 s2). Oncotarget (2016) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 s1
BioLegend Il2ra抗体(Biolegend, 3C7)被用于被用于流式细胞仪在小鼠样本上 (图 s1). Oncotarget (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 6
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 6). Nat Immunol (2016) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 6
BioLegend Il2ra抗体(Biolegend, 3C7)被用于被用于流式细胞仪在小鼠样本上 (图 6). Nat Immunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 7e
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 7e). Oncotarget (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5d
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5d). Gastroenterology (2016) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 6
BioLegend Il2ra抗体(BioLegend, 3C7)被用于被用于流式细胞仪在小鼠样本上 (图 6). J Transl Med (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3). Mucosal Immunol (2016) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 1
BioLegend Il2ra抗体(Biolegend, 3C7)被用于被用于流式细胞仪在小鼠样本上 (图 1). Sci Rep (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 7a
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 7a). J Exp Med (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:200; 图 s4
BioLegend Il2ra抗体(Biolegend, 102006)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 s4). Nat Commun (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s5
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s5). EMBO Mol Med (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:400; 图 s1a
BioLegend Il2ra抗体(BioLegend, 102008)被用于被用于流式细胞仪在小鼠样本上浓度为1:400 (图 s1a). Nat Commun (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2). Sci Rep (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1). Theranostics (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 6
BioLegend Il2ra抗体(BioLegend, 102038)被用于被用于流式细胞仪在小鼠样本上 (图 6). Oncotarget (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1c
BioLegend Il2ra抗体(BioLegend, pc61)被用于被用于流式细胞仪在小鼠样本上 (图 1c). Arthritis Rheumatol (2016) ncbi
大鼠 单克隆(3C7)
BioLegend Il2ra抗体(BioLegend, 101903)被用于. Mol Med Rep (2015) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 3
BioLegend Il2ra抗体(Biolegend, 3C7)被用于被用于流式细胞仪在小鼠样本上 (图 3). J Inflamm (Lond) (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 表 s1
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (表 s1). Biochem Biophys Res Commun (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上. Eur J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上. Microbes Infect (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4). J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上. Oncotarget (2015) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 1:200; 图 1
BioLegend Il2ra抗体(Biolegend, 101910)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 1). Nat Commun (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 6
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 6). PLoS Pathog (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上. J Clin Invest (2015) ncbi
大鼠 单克隆(PC61)
  • 抑制或激活实验; 小鼠
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于抑制或激活实验在小鼠样本上 和 被用于流式细胞仪在小鼠样本上. Sci Rep (2015) ncbi
大鼠 单克隆(PC61)
BioLegend Il2ra抗体(Biolegend, PC61.5)被用于. Sci Rep (2015) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, 3C7)被用于被用于流式细胞仪在小鼠样本上. Biomed Mater Eng (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1). Nat Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, PC61.5)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, 102006)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上. J Clin Invest (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5d
BioLegend Il2ra抗体(biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5d). Nat Commun (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
小鼠 单克隆(OX-39)
  • 流式细胞仪; 大鼠; 图 7
BioLegend Il2ra抗体(BioLegend, OX-39)被用于被用于流式细胞仪在大鼠样本上 (图 7). Eur J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, PC61.5)被用于被用于流式细胞仪在小鼠样本上. Dis Model Mech (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, clone PC61)被用于被用于流式细胞仪在小鼠样本上. Development (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2014) ncbi
小鼠 单克隆(OX-39)
BioLegend Il2ra抗体(BioLegend, OX-39)被用于. J Immunol (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, PC61)被用于被用于流式细胞仪在小鼠样本上. Mol Cell Biol (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(BioLegend, 102015)被用于被用于流式细胞仪在小鼠样本上. Ann Neurol (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
BioLegend Il2ra抗体(Biolegend, 102007)被用于被用于流式细胞仪在小鼠样本上. Exp Parasitol (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2g
BioLegend Il2ra抗体(BioLegend, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2g). J Leukoc Biol (2014) ncbi
Bio X Cell
大鼠 单克隆(PC-61.5.3)
  • 抑制或激活实验; 小鼠; ; 图 6c
Bio X Cell Il2ra抗体(Bio X Cell, PC61.5)被用于被用于抑制或激活实验在小鼠样本上浓度为 (图 6c). Sci Adv (2020) ncbi
大鼠 单克隆(PC-61.5.3)
  • 抑制或激活实验; 小鼠; 0.5 mg/mouse; 图 6e
Bio X Cell Il2ra抗体(BioXcell, PC61)被用于被用于抑制或激活实验在小鼠样本上浓度为0.5 mg/mouse (图 6e). J Biol Chem (2017) ncbi
安迪生物R&D
domestic goat 多克隆
  • 免疫组化; 小鼠; 图 2d
安迪生物R&D Il2ra抗体(R&D, AF2438)被用于被用于免疫组化在小鼠样本上 (图 2d). Sci Rep (2020) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(MEM-181)
  • 免疫细胞化学; 小鼠; 1:1000
艾博抗(上海)贸易有限公司 Il2ra抗体(Abcam, ab8235)被用于被用于免疫细胞化学在小鼠样本上浓度为1:1000. J Comp Neurol (2014) ncbi
Tonbo Biosciences
Rattus 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 图 s5i
Tonbo Biosciences Il2ra抗体(Tonbo, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 s5i). Nature (2017) ncbi
Rattus 单克隆(PC61.5)
  • 流式细胞仪; 小鼠; 表 s1
Tonbo Biosciences Il2ra抗体(TONBO, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (表 s1). Biochem Biophys Res Commun (2015) ncbi
碧迪BD
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2h
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2h). Sci Adv (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3b, 4b
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3b, 4b). Biomolecules (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:25; 图 s5
碧迪BD Il2ra抗体(BD Bioscience, 564424)被用于被用于流式细胞仪在小鼠样本上浓度为1:25 (图 s5). Science (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2b
碧迪BD Il2ra抗体(BD, 552880)被用于被用于流式细胞仪在小鼠样本上 (图 2b). Cell Rep (2019) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 3e
碧迪BD Il2ra抗体(BD Pharmigen, 553070)被用于被用于流式细胞仪在小鼠样本上 (图 3e). Nature (2019) ncbi
Rattus 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s8b
碧迪BD Il2ra抗体(BD, 564022)被用于被用于流式细胞仪在小鼠样本上 (图 s8b). Nat Commun (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4a
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4a). Nature (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s1
碧迪BD Il2ra抗体(BD Biosciences, 564023)被用于被用于流式细胞仪在小鼠样本上 (图 s1). J Clin Invest (2019) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 1:500; 图 1h
碧迪BD Il2ra抗体(BD Biosciences, 7D4)被用于被用于流式细胞仪在小鼠样本上浓度为1:500 (图 1h). Nat Commun (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3c, 4d
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3c, 4d). Proc Natl Acad Sci U S A (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s8a
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s8a). J Clin Invest (2019) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2f
碧迪BD Il2ra抗体(BD, 553866)被用于被用于流式细胞仪在小鼠样本上 (图 2f). Cell (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s17a
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s17a). J Clin Invest (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1g
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1g). Cell Rep (2018) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 s2a
碧迪BD Il2ra抗体(BD Biosciences, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 s2a). J Clin Invest (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:200; 图 3a
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 3a). Heliyon (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s4e
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s4e). J Exp Med (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s2a
碧迪BD Il2ra抗体(BD Bioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s2a). Proc Natl Acad Sci U S A (2018) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 6a
碧迪BD Il2ra抗体(BD Bioscience, 558642)被用于被用于流式细胞仪在小鼠样本上 (图 6a). J Immunol (2018) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3a
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3a). Sci Rep (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1d
碧迪BD Il2ra抗体(BD Biosciences, 561038)被用于被用于流式细胞仪在小鼠样本上 (图 1d). Cancer Cell (2017) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 1d
碧迪BD Il2ra抗体(BD Biosciences, 558643)被用于被用于流式细胞仪在小鼠样本上 (图 1d). Cancer Cell (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s6c
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s6c). Proc Natl Acad Sci U S A (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s2k
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s2k). Nature (2017) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 2e
碧迪BD Il2ra抗体(BD, 553072)被用于被用于流式细胞仪在小鼠样本上 (图 2e). J Exp Med (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 6c
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 6c). Cell Immunol (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1a
碧迪BD Il2ra抗体(BD Biosciences, 557658)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Immunity (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3
碧迪BD Il2ra抗体(BD Bioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3). Proc Natl Acad Sci U S A (2017) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 s1
碧迪BD Il2ra抗体(BD Biosciences, 3C7)被用于被用于流式细胞仪在小鼠样本上 (图 s1). J Immunol (2017) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 1a
碧迪BD Il2ra抗体(BD Biosciences, 3C7)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Int J Parasitol (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1b
碧迪BD Il2ra抗体(BD, 562606)被用于被用于流式细胞仪在小鼠样本上 (图 1b). Immun Inflamm Dis (2017) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 6e
碧迪BD Il2ra抗体(BD Biosciences, 553075)被用于被用于流式细胞仪在小鼠样本上 (图 6e). PLoS ONE (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s1b
碧迪BD Il2ra抗体(BD Pharmingen, PC6.1)被用于被用于流式细胞仪在小鼠样本上 (图 s1b). Mucosal Immunol (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上. J Clin Invest (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s2
碧迪BD Il2ra抗体(BD Pharmigen, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s2). Front Immunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3c
碧迪BD Il2ra抗体(BD Bioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3c). Oncotarget (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1c
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1c). J Exp Med (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:100; 图 5f
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 5f). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 s5a
碧迪BD Il2ra抗体(BD Biosciences, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 s5a). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4d
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4d). J Exp Med (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 4b
碧迪BD Il2ra抗体(BD Bioscience, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 4b). J Clin Invest (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2d
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2d). J Immunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s2b
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s2b). Mucosal Immunol (2017) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s4e
碧迪BD Il2ra抗体(BD Biosciences, 553866)被用于被用于流式细胞仪在小鼠样本上 (图 s4e). Nat Immunol (2016) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 1a
碧迪BD Il2ra抗体(BD, 553075)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Genes Dev (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD, 557192)被用于被用于流式细胞仪在小鼠样本上. Cell (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:200
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上浓度为1:200. Cell Metab (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 1a
碧迪BD Il2ra抗体(BD, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 1a). J Immunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4a
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4a). J Immunol (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 1e
碧迪BD Il2ra抗体(BD Pharmingen, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 1e). J Immunol (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, 553072)被用于被用于流式细胞仪在小鼠样本上. Nat Commun (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 s1
碧迪BD Il2ra抗体(BD Pharmingen, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 s1). PLoS ONE (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s8a
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s8a). Infect Immun (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4a
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4a). J Immunol (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 1:100
碧迪BD Il2ra抗体(BD, 553072)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. Nat Immunol (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 s2
碧迪BD Il2ra抗体(BD Biosciences, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 s2). J Immunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s2
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s2). J Immunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4
碧迪BD Il2ra抗体(BD Biosciences, 552880)被用于被用于流式细胞仪在小鼠样本上 (图 4). Sci Rep (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1A
  • 免疫印迹; 小鼠; 1:500; 图 1C
碧迪BD Il2ra抗体(BD, 557425)被用于被用于流式细胞仪在小鼠样本上 (图 1A) 和 被用于免疫印迹在小鼠样本上浓度为1:500 (图 1C). PLoS ONE (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上. Nat Immunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2
碧迪BD Il2ra抗体(BD Pharmingen, 561038)被用于被用于流式细胞仪在小鼠样本上 (图 2). PLoS Pathog (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s4
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s4). Sci Rep (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 3e
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 3e). Oncotarget (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s3b
碧迪BD Il2ra抗体(Beckon Dickinson, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s3b). Biol Open (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:200; 图 3
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 3). Nat Immunol (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 人类; 图 1d
碧迪BD Il2ra抗体(BD, 7D4)被用于被用于流式细胞仪在人类样本上 (图 1d). PLoS ONE (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2b
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2b). PLoS ONE (2016) ncbi
大鼠 单克隆(7D4)
  • 免疫细胞化学; 小鼠; 1:25; 图 8
碧迪BD Il2ra抗体(BD Biosciences, 550529)被用于被用于免疫细胞化学在小鼠样本上浓度为1:25 (图 8). J Immunol Res (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 4
碧迪BD Il2ra抗体(BD Biosciences, 7d4)被用于被用于流式细胞仪在小鼠样本上 (图 4). Oncoimmunology (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD, 553866)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4
碧迪BD Il2ra抗体(BD Bioscience, 552880)被用于被用于流式细胞仪在小鼠样本上 (图 4). Nat Commun (2016) ncbi
大鼠 单克隆(7D4)
  • 免疫细胞化学; 小鼠; 1:150; 图 1
碧迪BD Il2ra抗体(BD Pharmingen, 553070)被用于被用于免疫细胞化学在小鼠样本上浓度为1:150 (图 1). Nat Commun (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 s3a
碧迪BD Il2ra抗体(BD PharMingen, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 s3a). J Immunol (2016) ncbi
大鼠 单克隆(7D4)
  • 免疫组化; 人类; 1:25; 图 4
碧迪BD Il2ra抗体(BD Pharmingen, 7D4 (RUO))被用于被用于免疫组化在人类样本上浓度为1:25 (图 4). Sci Rep (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD, 553866)被用于被用于流式细胞仪在小鼠样本上. Nature (2016) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 4
碧迪BD Il2ra抗体(BD, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 4). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠; 图 3a
碧迪BD Il2ra抗体(BD Biosciences, 3C7)被用于被用于流式细胞仪在小鼠样本上 (图 3a). Immunol Cell Biol (2016) ncbi
大鼠 单克隆(PC61)
  • 免疫细胞化学; 小鼠
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于免疫细胞化学在小鼠样本上. Eur J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上. Eur J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2). Sci Rep (2015) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 s1
碧迪BD Il2ra抗体(BD Pharmingen, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 s1). Mucosal Immunol (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 s3
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 s3). Leukemia (2016) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. Front Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:100; 图 s3
碧迪BD Il2ra抗体(BD Pharmingen, 551071)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s3). Nat Commun (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 表 s1
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (表 s1). Biochem Biophys Res Commun (2015) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 1:100; 图 s4
碧迪BD Il2ra抗体(BD, 7D4)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s4). PLoS ONE (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5
  • 免疫细胞化学; 小鼠; 图 4
碧迪BD Il2ra抗体(BD Bioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5) 和 被用于免疫细胞化学在小鼠样本上 (图 4). Nat Immunol (2015) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 1a
碧迪BD Il2ra抗体(BD Biosciences, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Vaccine (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4). Nat Commun (2015) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 图 4
碧迪BD Il2ra抗体(BD Biosciences, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 4). Nat Commun (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1
碧迪BD Il2ra抗体(BD Pharmigen, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1). PLoS ONE (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 8
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 8). PLoS ONE (2015) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠; 1:100; 图 s13
碧迪BD Il2ra抗体(BD, 563598)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s13). Nat Commun (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 1). J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 1
碧迪BD Il2ra抗体(BD Biosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上 (图 1). Clin Sci (Lond) (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 8
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 8). J Clin Invest (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1.0 ug/ml; 图 3
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上浓度为1.0 ug/ml (图 3). Immunol Cell Biol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 人类; 图 5
碧迪BD Il2ra抗体(BD Bioscience, PC61.5.3)被用于被用于流式细胞仪在人类样本上 (图 5). Cell Res (2015) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, 7D4)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 4
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 4). J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5
碧迪BD Il2ra抗体(BD Bioscience, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5). J Immunol (2015) ncbi
大鼠 单克隆(7D4)
  • 免疫组化-冰冻切片; 小鼠; 图 1
  • 流式细胞仪; 小鼠; 图 1
碧迪BD Il2ra抗体(BD, clone 7D4)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 1) 和 被用于流式细胞仪在小鼠样本上 (图 1). Eur J Immunol (2015) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD, 7D4)被用于被用于流式细胞仪在小鼠样本上. Nature (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上. Nature (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2). Transpl Int (2015) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD, 7D4)被用于被用于流式细胞仪在小鼠样本上. Neurotherapeutics (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Pharmingen, 7D4)被用于被用于流式细胞仪在小鼠样本上. Immunology (2015) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, 3C7)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2). J Exp Med (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 5
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 5). J Exp Med (2014) ncbi
大鼠 单克隆(3C7)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, 3C7)被用于被用于流式细胞仪在小鼠样本上. Immunobiology (2015) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. Proc Natl Acad Sci U S A (2014) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, 7D4)被用于被用于流式细胞仪在小鼠样本上. Proc Natl Acad Sci U S A (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上. Cancer Immunol Res (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Pharmingen, PC61)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 1:200; 图 6c
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 6c). Nat Commun (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Bioscience, PC61.5)被用于被用于流式细胞仪在小鼠样本上. Virol Sin (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. Immunology (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD, PC61)被用于被用于流式细胞仪在小鼠样本上. FASEB J (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61.5)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD, 551071)被用于被用于流式细胞仪在小鼠样本上. Nat Med (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. Mucosal Immunol (2014) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2013) ncbi
大鼠 单克隆(7D4)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, 7D4)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2013) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2013) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠; 图 2
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于流式细胞仪在小鼠样本上 (图 2). J Cardiothorac Surg (2012) ncbi
大鼠 单克隆(PC61)
  • 抑制或激活实验; 小鼠; 图 2
碧迪BD Il2ra抗体(BD Biosciences, PC61)被用于被用于抑制或激活实验在小鼠样本上 (图 2). Nat Immunol (2012) ncbi
大鼠 单克隆(7D4)
  • 染色质免疫沉淀 ; 小鼠
碧迪BD Il2ra抗体(BD-Pharmingen, 7D4)被用于被用于染色质免疫沉淀 在小鼠样本上. J Immunol (2012) ncbi
大鼠 单克隆(PC61)
  • 流式细胞仪; 小鼠
碧迪BD Il2ra抗体(BD PharMingen, PC61)被用于被用于流式细胞仪在小鼠样本上. Nat Immunol (2006) ncbi
文章列表
  1. Yoshida S, Miyagawa S, Toyofuku T, Fukushima S, Kawamura T, Kawamura A, et al. Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation. Sci Rep. 2020;10:4593 pubmed 出版商
  2. Fu Y, Ding Y, Wang Q, Zhu F, Tan Y, Lu X, et al. Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. Sci Adv. 2020;6:eaay9269 pubmed 出版商
  3. Parisi G, Saco J, Salazar F, Tsoi J, Krystofinski P, Puig Saus C, et al. Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist. Nat Commun. 2020;11:660 pubmed 出版商
  4. Singh K, Leu J, Barnoud T, Vonteddu P, Gnanapradeepan K, Lin C, et al. African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxin. Nat Commun. 2020;11:473 pubmed 出版商
  5. Williford J, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell T, et al. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357 pubmed 出版商
  6. Lecocq Q, Zeven K, De Vlaeminck Y, Martens S, Massa S, Goyvaerts C, et al. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use. Biomolecules. 2019;9: pubmed 出版商
  7. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed 出版商
  8. Collins N, Han S, Enamorado M, Link V, Huang B, Moseman E, et al. The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction. Cell. 2019;178:1088-1101.e15 pubmed 出版商
  9. Rosshart S, Herz J, Vassallo B, Hunter A, Wall M, Badger J, et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science. 2019;365: pubmed 出版商
  10. Kawalkowska J, Ogbechi J, Venables P, Williams R. cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs. Sci Adv. 2019;5:eaaw5422 pubmed 出版商
  11. Yen W, Sharma R, Cols M, Lau C, Chaudhry A, Chowdhury P, et al. Distinct Requirements of CHD4 during B Cell Development and Antibody Response. Cell Rep. 2019;27:1472-1486.e5 pubmed 出版商
  12. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed 出版商
  13. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed 出版商
  14. Esterházy D, Canesso M, Mesin L, Muller P, de Castro T, Lockhart A, et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature. 2019;569:126-130 pubmed 出版商
  15. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed 出版商
  16. Visekruna A, Hartmann S, Sillke Y, Glauben R, Fischer F, Raifer H, et al. Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells. J Clin Invest. 2019;129:1972-1983 pubmed 出版商
  17. Qian L, Bajana S, Georgescu C, Peng V, Wang H, Adrianto I, et al. Suppression of ILC2 differentiation from committed T cell precursors by E protein transcription factors. J Exp Med. 2019;216:884-899 pubmed 出版商
  18. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed 出版商
  19. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed 出版商
  20. Michaels Y, Barnkob M, Barbosa H, Baeumler T, Thompson M, Andre V, et al. Precise tuning of gene expression levels in mammalian cells. Nat Commun. 2019;10:818 pubmed 出版商
  21. Anandagoda N, Willis J, Hertweck A, Roberts L, Jackson I, Gökmen M, et al. microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance. J Clin Invest. 2019;129:1257-1271 pubmed 出版商
  22. Silva D, Yu S, Ulge U, Spangler J, Jude K, Labao Almeida C, et al. De novo design of potent and selective mimics of IL-2 and IL-15. Nature. 2019;565:186-191 pubmed 出版商
  23. Wang J, Sanmamed M, Datar I, Su T, Ji L, Sun J, et al. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3. Cell. 2019;176:334-347.e12 pubmed 出版商
  24. Li F, Zeng Z, Xing S, Gullicksrud J, Shan Q, Choi J, et al. Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun. 2018;9:5452 pubmed 出版商
  25. Mantri C, St John A. Immune synapses between mast cells and γδ T cells limit viral infection. J Clin Invest. 2019;129:1094-1108 pubmed 出版商
  26. Chorro L, Suzuki M, Chin S, Williams T, Snapp E, Odagiu L, et al. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat Commun. 2018;9:5368 pubmed 出版商
  27. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed 出版商
  28. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed 出版商
  29. Garić D, Tao S, Ahmed E, Youssef M, Kanagaratham C, Shah J, et al. Depletion of BAFF cytokine exacerbates infection in Pseudomonas aeruginosa infected mice. J Cyst Fibros. 2019;18:349-356 pubmed 出版商
  30. Atretkhany K, Mufazalov I, Dunst J, Kuchmiy A, Gogoleva V, Andruszewski D, et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc Natl Acad Sci U S A. 2018;115:13051-13056 pubmed 出版商
  31. Dong S, Harrington B, Hu E, Greene J, Lehman A, Tran M, et al. PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression. J Clin Invest. 2019;129:122-136 pubmed 出版商
  32. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed 出版商
  33. Wilgenburg B, Loh L, Chen Z, Pediongco T, Wang H, Shi M, et al. MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun. 2018;9:4706 pubmed 出版商
  34. Singh A, Khare P, Obaid A, Conlon K, Basrur V, Depinho R, et al. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. Nat Commun. 2018;9:4515 pubmed 出版商
  35. Schrand B, Clark E, Levay A, Capote A, Martínez O, Brenneman R, et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun. 2018;9:3348 pubmed 出版商
  36. Cheng Y, Zhu X, Wang X, Zhuang Q, Huyan X, Sun X, et al. Trichinella spiralis Infection Mitigates Collagen-Induced Arthritis via Programmed Death 1-Mediated Immunomodulation. Front Immunol. 2018;9:1566 pubmed 出版商
  37. Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt F, Liniany L, Knight D, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. 2018;49:247-263.e7 pubmed 出版商
  38. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed 出版商
  39. Splitt S, Souza S, Valentine K, Castellanos B, Curd A, Hoyer K, et al. PD-L1, TIM-3, and CTLA-4 Blockade Fails To Promote Resistance to Secondary Infection with Virulent Strains of Toxoplasma gondii. Infect Immun. 2018;86: pubmed 出版商
  40. Vendetti F, Karukonda P, Clump D, Teo T, Lalonde R, Nugent K, et al. ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation. J Clin Invest. 2018;128:3926-3940 pubmed 出版商
  41. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed 出版商
  42. Gu C, Borjabad A, Hadas E, Kelschenbach J, Kim B, Chao W, et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathog. 2018;14:e1007061 pubmed 出版商
  43. Yao Y, Huang W, Li X, Li X, Qian J, Han H, et al. Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice. Front Immunol. 2018;9:965 pubmed 出版商
  44. Tanaka S, Pfleger C, Lai J, Roan F, Sun S, Ziegler S. KAP1 Regulates Regulatory T Cell Function and Proliferation in Both Foxp3-Dependent and -Independent Manners. Cell Rep. 2018;23:796-807 pubmed 出版商
  45. Varelias A, Bunting M, Ormerod K, Koyama M, Olver S, Straube J, et al. Recipient mucosal-associated invariant T cells control GVHD within the colon. J Clin Invest. 2018;128:1919-1936 pubmed 出版商
  46. Kornberg M, Bhargava P, Kim P, Putluri V, Snowman A, Putluri N, et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 2018;360:449-453 pubmed 出版商
  47. Lyons J, Ghazi P, Starchenko A, Tovaglieri A, Baldwin K, Poulin E, et al. The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile. PLoS Biol. 2018;16:e2002417 pubmed 出版商
  48. Olesen M, Christiansen J, Petersen S, Jensen P, Paslawski W, Romero Ramos M, et al. CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology. Heliyon. 2018;4:e00513 pubmed 出版商
  49. Gaddis D, Padgett L, Wu R, McSkimming C, Romines V, Taylor A, et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun. 2018;9:1095 pubmed 出版商
  50. Yeh C, Nojima T, Kuraoka M, Kelsoe G. Germinal center entry not selection of B cells is controlled by peptide-MHCII complex density. Nat Commun. 2018;9:928 pubmed 出版商
  51. Shakyawar D, Muralikrishna B, Radha V. C3G dynamically associates with nuclear speckles and regulates mRNA splicing. Mol Biol Cell. 2018;: pubmed 出版商
  52. Sockolosky J, Trotta E, Parisi G, Picton L, Su L, Le A, et al. Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science. 2018;359:1037-1042 pubmed 出版商
  53. Kornete M, Marone R, Jeker L. Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells. J Immunol. 2018;200:2489-2501 pubmed 出版商
  54. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed 出版商
  55. Fahl S, Coffey F, Kain L, Zarin P, Dunbrack R, Teyton L, et al. Role of a selecting ligand in shaping the murine γδ-TCR repertoire. Proc Natl Acad Sci U S A. 2018;115:1889-1894 pubmed 出版商
  56. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed 出版商
  57. Turner D, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, et al. Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma. J Immunol. 2018;200:1561-1569 pubmed 出版商
  58. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed 出版商
  59. Steinbuck M, Arakcheeva K, Winandy S. Novel TCR-Mediated Mechanisms of Notch Activation and Signaling. J Immunol. 2018;200:997-1007 pubmed 出版商
  60. Cowan J, Baik S, McCarthy N, Parnell S, White A, Jenkinson W, et al. Aire controls the recirculation of murine Foxp3+ regulatory T-cells back to the thymus. Eur J Immunol. 2018;48:844-854 pubmed 出版商
  61. Lynch J, Werder R, Loh Z, Sikder M, Curren B, Zhang V, et al. Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion. J Exp Med. 2018;215:537-557 pubmed 出版商
  62. Ibitokou S, Dillon B, Sinha M, Szczesny B, Delgadillo A, Reda Abdelrahman D, et al. Early Inhibition of Fatty Acid Synthesis Reduces Generation of Memory Precursor Effector T Cells in Chronic Infection. J Immunol. 2018;200:643-656 pubmed 出版商
  63. Iseka F, Goetz B, Mushtaq I, An W, Cypher L, Bielecki T, et al. Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. J Immunol. 2018;200:483-499 pubmed 出版商
  64. Harly C, Cam M, Kaye J, Bhandoola A. Development and differentiation of early innate lymphoid progenitors. J Exp Med. 2018;215:249-262 pubmed 出版商
  65. Mailer R, Gisterå A, Polyzos K, Ketelhuth D, Hansson G. Hypercholesterolemia Enhances T Cell Receptor Signaling and Increases the Regulatory T Cell Population. Sci Rep. 2017;7:15655 pubmed 出版商
  66. Robles Valero J, Lorenzo Martín L, Menacho Márquez M, Fernández Pisonero I, Abad A, Camos M, et al. A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2017;32:608-623.e9 pubmed 出版商
  67. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed 出版商
  68. Capece T, Walling B, Lim K, Kim K, Bae S, Chung H, et al. A novel intracellular pool of LFA-1 is critical for asymmetric CD8+ T cell activation and differentiation. J Cell Biol. 2017;216:3817-3829 pubmed 出版商
  69. Francis N, Every A, Ayodele B, Pike R, Mackie E, Pagel C. A T cell-specific knockout reveals an important role for protease-activated receptor 2 in lymphocyte development. Int J Biochem Cell Biol. 2017;92:95-103 pubmed 出版商
  70. Jung K, Heishi T, Incio J, Huang Y, Beech E, Pinter M, et al. Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer. Proc Natl Acad Sci U S A. 2017;114:10455-10460 pubmed 出版商
  71. Strandt H, Pinheiro D, Kaplan D, Wirth D, GRATZ I, Hammerl P, et al. Neoantigen Expression in Steady-State Langerhans Cells Induces CTL Tolerance. J Immunol. 2017;199:1626-1634 pubmed 出版商
  72. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed 出版商
  73. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed 出版商
  74. Chen J, Martindale J, Cramer C, Gorospe M, Atasoy U, Drew P, et al. The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells. J Biol Chem. 2017;292:14532-14543 pubmed 出版商
  75. Alloatti A, Rookhuizen D, Joannas L, Carpier J, Iborra S, Magalhaes J, et al. Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity. J Exp Med. 2017;214:2231-2241 pubmed 出版商
  76. Levine A, Mendoza A, Hemmers S, Moltedo B, Niec R, Schizas M, et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017;546:421-425 pubmed 出版商
  77. Seifert H, Benedek G, Liang J, Nguyen H, Kent G, Vandenbark A, et al. Sex differences in regulatory cells in experimental stroke. Cell Immunol. 2017;318:49-54 pubmed 出版商
  78. Chae W, Park J, Henegariu O, Yilmaz S, Hao L, Bothwell A. Membrane-bound Dickkopf-1 in Foxp3+ regulatory T cells suppresses T-cell-mediated autoimmune colitis. Immunology. 2017;152:265-275 pubmed 出版商
  79. Li C, Leng Y, Zhao B, Gao C, Du F, Jin N, et al. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases. Stem Cells. 2017;35:1719-1732 pubmed 出版商
  80. Miyazaki M, Miyazaki K, Chen K, Jin Y, Turner J, Moore A, et al. The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development. Immunity. 2017;46:818-834.e4 pubmed 出版商
  81. Torcellan T, Hampton H, Bailey J, Tomura M, Brink R, Chtanova T. In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. Proc Natl Acad Sci U S A. 2017;114:5677-5682 pubmed 出版商
  82. Taylor S, Huang Y, Mallett G, Stathopoulou C, Felizardo T, Sun M, et al. PD-1 regulates KLRG1+ group 2 innate lymphoid cells. J Exp Med. 2017;214:1663-1678 pubmed 出版商
  83. Chowdhary V, Krogman A, Tilahun A, Alexander M, David C, Rajagopalan G. Concomitant Disruption of CD4 and CD8 Genes Facilitates the Development of Double Negative ?? TCR+ Peripheral T Cells That Respond Robustly to Staphylococcal Superantigen. J Immunol. 2017;198:4413-4424 pubmed 出版商
  84. Acharya N, Penukonda S, Shcheglova T, Hagymasi A, Basu S, Srivastava P. Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Proc Natl Acad Sci U S A. 2017;114:5005-5010 pubmed 出版商
  85. Meinicke H, Bremser A, Brack M, Akeus P, Pearson C, Bullers S, et al. Tumour-associated changes in intestinal epithelial cells cause local accumulation of KLRG1+ GATA3+ regulatory T cells in mice. Immunology. 2017;152:74-88 pubmed 出版商
  86. Chien C, Yu H, Chen S, Chiang B. Characterization of c-Maf+Foxp3- Regulatory T Cells Induced by Repeated Stimulation of Antigen-Presenting B Cells. Sci Rep. 2017;7:46348 pubmed 出版商
  87. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed 出版商
  88. Bouziat R, Hinterleitner R, Brown J, Stencel Baerenwald J, Ikizler M, Mayassi T, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44-50 pubmed 出版商
  89. van der Vlugt L, Obieglo K, Ozir Fazalalikhan A, Sparwasser T, Haeberlein S, Smits H. Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function. Int J Parasitol. 2017;47:545-554 pubmed 出版商
  90. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed 出版商
  91. Tian L, Goldstein A, Wang H, Ching Lo H, Sun Kim I, Welte T, et al. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature. 2017;544:250-254 pubmed 出版商
  92. Katerndahl C, Heltemes Harris L, Willette M, Henzler C, Frietze S, Yang R, et al. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. Nat Immunol. 2017;18:694-704 pubmed 出版商
  93. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed 出版商
  94. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed 出版商
  95. Fisher S, Aston W, Chee J, Khong A, Cleaver A, Solin J, et al. Transient Treg depletion enhances therapeutic anti-cancer vaccination. Immun Inflamm Dis. 2017;5:16-28 pubmed 出版商
  96. Komegae E, Souza T, Grund L, Lima C, Lopes Ferreira M. Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis. PLoS ONE. 2017;12:e0171796 pubmed 出版商
  97. Szilagyi B, Triebus J, Kressler C, De Almeida M, Tierling S, Durek P, et al. Gut memories do not fade: epigenetic regulation of lasting gut homing receptor expression in CD4+ memory T cells. Mucosal Immunol. 2017;10:1443-1454 pubmed 出版商
  98. Huang R, Francois A, McGray A, Miliotto A, Odunsi K. Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer. Oncoimmunology. 2017;6:e1249561 pubmed 出版商
  99. Leech J, Lacey K, Mulcahy M, Medina E, McLoughlin R. IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections. J Immunol. 2017;198:2352-2365 pubmed 出版商
  100. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed 出版商
  101. Ramjee V, Li D, Manderfield L, Liu F, Engleka K, Aghajanian H, et al. Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction. J Clin Invest. 2017;127:899-911 pubmed 出版商
  102. Blanquiceth Y, Rodríguez Perea A, Tabares Guevara J, Correa L, Sánchez M, Ramirez Pineda J, et al. Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma. Front Immunol. 2016;7:620 pubmed 出版商
  103. Araujo L, Khim P, Mkhikian H, Mortales C, Demetriou M. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. elife. 2017;6: pubmed 出版商
  104. van der Weyden L, Arends M, Campbell A, Bald T, Wardle Jones H, Griggs N, et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017;541:233-236 pubmed 出版商
  105. Engler J, Kursawe N, Solano M, Patas K, Wehrmann S, Heckmann N, et al. Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy. Proc Natl Acad Sci U S A. 2017;114:E181-E190 pubmed 出版商
  106. Hayakawa M, Hayakawa H, Petrova T, Ritprajak P, Sutavani R, Jiménez Andrade G, et al. Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction. J Biol Chem. 2017;292:1762-1772 pubmed 出版商
  107. Lamprianou S, Gysemans C, Bou Saab J, Pontes H, Mathieu C, Meda P. Glibenclamide Prevents Diabetes in NOD Mice. PLoS ONE. 2016;11:e0168839 pubmed 出版商
  108. Wei Y, Lu C, Chen J, Cui G, Wang L, Yu T, et al. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget. 2017;8:70-82 pubmed 出版商
  109. Nish S, Zens K, Kratchmarov R, Lin W, Adams W, Chen Y, et al. CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med. 2017;214:39-47 pubmed 出版商
  110. Connor L, Tang S, Cognard E, Ochiai S, Hilligan K, Old S, et al. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. J Exp Med. 2017;214:125-142 pubmed 出版商
  111. Morita K, Okamura T, Inoue M, Komai T, Teruya S, Iwasaki Y, et al. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production. Proc Natl Acad Sci U S A. 2016;113:E8131-E8140 pubmed
  112. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  113. Le Q, Yao W, Chen Y, Yan B, Liu C, Yuan M, et al. GRK6 regulates ROS response and maintains hematopoietic stem cell self-renewal. Cell Death Dis. 2016;7:e2478 pubmed 出版商
  114. Khan S, Woodruff E, Trapecar M, Fontaine K, Ezaki A, Borbet T, et al. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016;213:2913-2929 pubmed
  115. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  116. Cummings R, Barbet G, Bongers G, Hartmann B, Gettler K, Muniz L, et al. Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs. Nature. 2016;539:565-569 pubmed 出版商
  117. Park K, Mikulski Z, Seo G, Andreyev A, Marcovecchio P, Blatchley A, et al. The transcription factor NR4A3 controls CD103+ dendritic cell migration. J Clin Invest. 2016;126:4603-4615 pubmed 出版商
  118. Hu Y, Kim J, He K, Wan Q, Kim J, Flach M, et al. Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med. 2016;213:2759-2772 pubmed
  119. Jirmo A, Daluege K, Happle C, Albrecht M, Dittrich A, Busse M, et al. IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod). J Immunol. 2016;197:4219-4227 pubmed
  120. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  121. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed 出版商
  122. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed 出版商
  123. Yu S, Pearson A, Lim R, Rodgers D, Li S, Parker H, et al. Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate. Mol Ther. 2016;24:2078-2089 pubmed 出版商
  124. Coursey T, Bian F, Zaheer M, Pflugfelder S, Volpe E, de Paiva C. Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells. Mucosal Immunol. 2017;10:743-756 pubmed 出版商
  125. Gerriets V, Kishton R, Johnson M, Cohen S, Siska P, Nichols A, et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol. 2016;17:1459-1466 pubmed 出版商
  126. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  127. Hu Y, Zhang Z, Kashiwagi M, Yoshida T, Joshi I, Jena N, et al. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia. Genes Dev. 2016;30:1971-90 pubmed 出版商
  128. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed 出版商
  129. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  130. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed 出版商
  131. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed 出版商
  132. Butcher M, Filipowicz A, Waseem T, McGary C, Crow K, Magilnick N, et al. Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFN?+ Th1/Tregs. Circ Res. 2016;119:1190-1203 pubmed 出版商
  133. Ruan G, Tao B, Wang D, Li Y, Wu J, Yin G. Chinese herbal medicine formula Gu-Ben-Fang-Xiao-Tang attenuates airway inflammation by modulating Th17/Treg balance in an ovalbumin-induced murine asthma model. Exp Ther Med. 2016;12:1428-1434 pubmed
  134. Xia G, Wu S, Zhang Y. Anti-4-1BB monoclonal antibodies attenuate concanavalin A-induced immune-mediated liver injury in mice. Exp Ther Med. 2016;12:1263-1268 pubmed
  135. Fabbiano S, Suárez Zamorano N, Rigo D, Veyrat Durebex C, Stevanovic Dokic A, Colin D, et al. Caloric Restriction Leads to Browning of White Adipose Tissue through Type 2 Immune Signaling. Cell Metab. 2016;24:434-446 pubmed 出版商
  136. Vogel K, Bell L, Galloway A, Ahlfors H, Turner M. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016;197:2673-2685 pubmed 出版商
  137. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed 出版商
  138. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed 出版商
  139. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed 出版商
  140. Carow B, Gao Y, Coquet J, Reilly M, Rottenberg M. lck-Driven Cre Expression Alters T Cell Development in the Thymus and the Frequencies and Functions of Peripheral T Cell Subsets. J Immunol. 2016;197:2261-8 pubmed 出版商
  141. Shi L, Fu T, Guan B, Chen J, Blando J, Allison J, et al. Interdependent IL-7 and IFN-? signalling in T-cell controls tumour eradication by combined ?-CTLA-4+?-PD-1 therapy. Nat Commun. 2016;7:12335 pubmed 出版商
  142. Shi Y, Wu W, Chai Q, Li Q, Hou Y, Xia H, et al. LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nat Commun. 2016;7:12369 pubmed 出版商
  143. Zhao Y, Chu X, Chen J, Wang Y, Gao S, Jiang Y, et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun. 2016;7:12368 pubmed 出版商
  144. Pizzolla A, Oh D, Luong S, Prickett S, Henstridge D, Febbraio M, et al. High Fat Diet Inhibits Dendritic Cell and T Cell Response to Allergens but Does Not Impair Inhalational Respiratory Tolerance. PLoS ONE. 2016;11:e0160407 pubmed 出版商
  145. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed 出版商
  146. Ferreirinha P, Pérez Cabezas B, Correia A, Miyazawa B, França A, Carvalhais V, et al. Poly-N-Acetylglucosamine Production by Staphylococcus epidermidis Cells Increases Their In Vivo Proinflammatory Effect. Infect Immun. 2016;84:2933-43 pubmed 出版商
  147. Liu W, Kang S, Huang Z, Wu C, Jin H, Maine C, et al. A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med. 2016;213:1901-19 pubmed 出版商
  148. Lai M, Gonzalez Martin A, Cooper A, Oda H, Jin H, Shepherd J, et al. Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs. Nat Commun. 2016;7:12207 pubmed 出版商
  149. Yoshioka D, Kajiwara C, Ishii Y, Umeki K, Hiramatsu K, Kadota J, et al. Efficacy of ?-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia. Antimicrob Agents Chemother. 2016;60:6146-54 pubmed 出版商
  150. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed 出版商
  151. Biton J, Khaleghparast Athari S, Thiolat A, Santinon F, Lemeiter D, Hervé R, et al. In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. J Immunol. 2016;197:1708-19 pubmed 出版商
  152. Seifert A, Zeng S, Zhang J, Kim T, Cohen N, Beckman M, et al. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clin Cancer Res. 2017;23:454-465 pubmed 出版商
  153. Chen S, Miyazaki M, Chandra V, Fisch K, Chang A, Murre C. Id3 Orchestrates Germinal Center B Cell Development. Mol Cell Biol. 2016;36:2543-52 pubmed 出版商
  154. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed 出版商
  155. Luo W, Li S, Li C, Lian H, Yang Q, Zhong B, et al. iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING. Nat Immunol. 2016;17:1057-66 pubmed 出版商
  156. Rackov G, Hernandez Jimenez E, Shokri R, Carmona Rodríguez L, Manes S, Alvarez Mon M, et al. p21 mediates macrophage reprogramming through regulation of p50-p50 NF-?B and IFN-?. J Clin Invest. 2016;126:3089-103 pubmed 出版商
  157. Drake L, Iijima K, Bartemes K, Kita H. Group 2 Innate Lymphoid Cells Promote an Early Antibody Response to a Respiratory Antigen in Mice. J Immunol. 2016;197:1335-42 pubmed 出版商
  158. Stifter K, Schuster C, Schlosser M, Boehm B, Schirmbeck R. Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination. Sci Rep. 2016;6:29419 pubmed 出版商
  159. Keil M, Sonner J, Lanz T, Oezen I, Bunse T, Bittner S, et al. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. J Neuroimmunol. 2016;297:117-26 pubmed 出版商
  160. Zea A, Stewart T, Ascani J, Tate D, Finkel Jimenez B, Wilk A, et al. Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?. PLoS ONE. 2016;11:e0157907 pubmed 出版商
  161. Orta Mascaró M, Consuegra Fernández M, Carreras E, Roncagalli R, Carreras Sureda A, Alvarez P, et al. CD6 modulates thymocyte selection and peripheral T cell homeostasis. J Exp Med. 2016;213:1387-97 pubmed 出版商
  162. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed 出版商
  163. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed 出版商
  164. Rudolph H, Klopstein A, Gruber I, Blatti C, Lyck R, Engelhardt B. Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro. Eur J Immunol. 2016;46:2187-203 pubmed 出版商
  165. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed 出版商
  166. Kathania M, Khare P, Zeng M, Cantarel B, Zhang H, Ueno H, et al. Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-?t ubiquitination. Nat Immunol. 2016;17:997-1004 pubmed 出版商
  167. Stentzel S, Teufelberger A, Nordengrün M, Kolata J, Schmidt F, Van Crombruggen K, et al. Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus. J Allergy Clin Immunol. 2017;139:492-500.e8 pubmed 出版商
  168. De Grove K, Provoost S, Hendriks R, McKenzie A, Seys L, Kumar S, et al. Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses. J Allergy Clin Immunol. 2017;139:246-257.e4 pubmed 出版商
  169. Gu L, Deng W, Sun X, Zhou H, Xu Q. Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance. Mol Med Rep. 2016;14:1153-61 pubmed 出版商
  170. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed 出版商
  171. Wang T, Pan D, Zhou Z, You Y, Jiang C, Zhao X, et al. Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut. PLoS Pathog. 2016;12:e1005662 pubmed 出版商
  172. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed 出版商
  173. Sujino T, London M, Hoytema van Konijnenburg D, Rendon T, Buch T, Silva H, et al. Tissue adaptation of regulatory and intraepithelial CD4? T cells controls gut inflammation. Science. 2016;352:1581-6 pubmed 出版商
  174. Stein S, Mack E, Rome K, Pajcini K, Ohtani T, Xu L, et al. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL. PLoS ONE. 2016;11:e0155408 pubmed 出版商
  175. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed 出版商
  176. Brandstätter O, Schanz O, Vorac J, König J, Mori T, Maruyama T, et al. Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci Rep. 2016;6:26091 pubmed 出版商
  177. Contreras F, Prado C, Gonzalez H, Franz D, Osorio Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol. 2016;196:4143-9 pubmed 出版商
  178. Rao E, Zhang Y, Li Q, Hao J, Egilmez N, Suttles J, et al. AMPK-dependent and independent effects of AICAR and compound C on T-cell responses. Oncotarget. 2016;7:33783-95 pubmed 出版商
  179. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed 出版商
  180. Stier M, Bloodworth M, Toki S, Newcomb D, Goleniewska K, Boyd K, et al. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin. J Allergy Clin Immunol. 2016;138:814-824.e11 pubmed 出版商
  181. Salao K, Jiang L, Li H, Tsai V, Husaini Y, Curmi P, et al. CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis. Biol Open. 2016;5:620-30 pubmed 出版商
  182. Swamy M, Pathak S, Grzes K, Damerow S, Sinclair L, van Aalten D, et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat Immunol. 2016;17:712-20 pubmed 出版商
  183. Carofino B, Ayanga B, Tracey L, Brooke Bisschop T, Justice M. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL. Biol Open. 2016;5:645-53 pubmed 出版商
  184. Galloway A, Saveliev A, Łukasiak S, Hodson D, Bolland D, Balmanno K, et al. RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence. Science. 2016;352:453-9 pubmed 出版商
  185. Li Z, Hodgkinson T, Gothard E, Boroumand S, Lamb R, Cummins I, et al. Epidermal Notch1 recruits RORγ(+) group 3 innate lymphoid cells to orchestrate normal skin repair. Nat Commun. 2016;7:11394 pubmed 出版商
  186. O Leary C, Riling C, Spruce L, Ding H, Kumar S, Deng G, et al. Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nat Commun. 2016;7:11226 pubmed 出版商
  187. Goldstein J, Burlion A, Zaragoza B, Sendeyo K, Polansky J, Huehn J, et al. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression. PLoS ONE. 2016;11:e0153682 pubmed 出版商
  188. Ufimtseva E. Differences between Mycobacterium-Host Cell Relationships in Latent Tuberculous Infection of Mice Ex Vivo and Mycobacterial Infection of Mouse Cells In Vitro. J Immunol Res. 2016;2016:4325646 pubmed 出版商
  189. Fend L, Remy Ziller C, Foloppe J, Kempf J, Cochin S, Barraud L, et al. Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment. Oncoimmunology. 2016;5:e1080414 pubmed
  190. Seidel P, Remus M, Delacher M, Grigaravicius P, Reuss D, Frappart L, et al. Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis. Oncotarget. 2016;7:23006-18 pubmed 出版商
  191. Barsoumian H, Yolcu E, Shirwan H. 4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell Suppression. PLoS ONE. 2016;11:e0153088 pubmed 出版商
  192. Braun J, Meixner A, Brachner A, Foisner R. The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis. PLoS ONE. 2016;11:e0152278 pubmed 出版商
  193. Yang Y, Xu J, Chen H, Fei X, Tang Y, Yan Y, et al. MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells. Oncotarget. 2016;7:17520-31 pubmed 出版商
  194. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed 出版商
  195. McFarland B, Marks M, Rowse A, Fehling S, Gerigk M, Qin H, et al. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma. Oncotarget. 2016;7:20621-35 pubmed 出版商
  196. Tosiek M, Fiette L, El Daker S, Eberl G, Freitas A. IL-15-dependent balance between Foxp3 and RORγt expression impacts inflammatory bowel disease. Nat Commun. 2016;7:10888 pubmed 出版商
  197. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed 出版商
  198. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed 出版商
  199. Wong H, Jin G, Cao R, Zhang S, Cao Y, Zhou Z. MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis. Nat Commun. 2016;7:10824 pubmed 出版商
  200. Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Rea D, Barbieri A, et al. A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice. J Transl Med. 2016;14:58 pubmed 出版商
  201. Pelly V, Kannan Y, Coomes S, Entwistle L, Rückerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol. 2016;9:1407-1417 pubmed 出版商
  202. Xiong Y, Ahmad S, Iwami D, Brinkman C, Bromberg J. T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function. J Immunol. 2016;196:2526-40 pubmed 出版商
  203. Freeman B, Ogle B. Viral-mediated fusion of mesenchymal stem cells with cells of the infarcted heart hinders healing via decreased vascularization and immune modulation. Sci Rep. 2016;6:20283 pubmed 出版商
  204. Haque M, Song J, Fino K, Sandhu P, Song X, Lei F, et al. Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity. Sci Rep. 2016;6:20588 pubmed 出版商
  205. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed 出版商
  206. Atkinson S, Hoffmann U, Hamann A, Bach E, Danneskiold Samsøe N, Kristiansen K, et al. Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade. Dis Model Mech. 2016;9:427-40 pubmed 出版商
  207. Thornton T, Delgado P, Chen L, Salas B, Krementsov D, Fernández M, et al. Inactivation of nuclear GSK3β by Ser(389) phosphorylation promotes lymphocyte fitness during DNA double-strand break response. Nat Commun. 2016;7:10553 pubmed 出版商
  208. Chandrasekaran U, Yi W, Gupta S, Weng C, Giannopoulou E, Chinenov Y, et al. Regulation of Effector Treg Cells in Murine Lupus. Arthritis Rheumatol. 2016;68:1454-66 pubmed 出版商
  209. Bothur E, Raifer H, Haftmann C, Stittrich A, Brüstle A, Brenner D, et al. Antigen receptor-mediated depletion of FOXP3 in induced regulatory T-lymphocytes via PTPN2 and FOXO1. Nat Commun. 2015;6:8576 pubmed 出版商
  210. Luchsinger L, de Almeida M, Corrigan D, Mumau M, Snoeck H. Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid potential. Nature. 2016;529:528-31 pubmed 出版商
  211. Kuipers H, Rieck M, Gurevich I, Nagy N, Butte M, Negrin R, et al. Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc Natl Acad Sci U S A. 2016;113:1339-44 pubmed 出版商
  212. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed 出版商
  213. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed 出版商
  214. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed 出版商
  215. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed 出版商
  216. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed 出版商
  217. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed 出版商
  218. Wei R, Hu Y, Dong F, Xu X, Hu A, Gao G. Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells. Immunol Cell Biol. 2016;94:388-99 pubmed 出版商
  219. Onodera T, Fukuhara A, Jang M, Shin J, Aoi K, Kikuta J, et al. Adipose tissue macrophages induce PPARγ-high FOXP3(+) regulatory T cells. Sci Rep. 2015;5:16801 pubmed 出版商
  220. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed 出版商
  221. Arriola Apelo S, Neuman J, Baar E, Syed F, Cummings N, Brar H, et al. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell. 2016;15:28-38 pubmed 出版商
  222. Riquelme S, Pogu J, Anegon I, Bueno S, Kalergis A. Carbon monoxide impairs mitochondria-dependent endosomal maturation and antigen presentation in dendritic cells. Eur J Immunol. 2015;45:3269-88 pubmed 出版商
  223. Patel M, Jacobson B, Ji Y, Drees J, Tang S, Xiong K, et al. Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer. Oncotarget. 2015;6:33165-77 pubmed 出版商
  224. Ladell K, Hazenberg M, Fitch M, Emson C, McEvoy Hein Asgarian B, Mold J, et al. Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1?: Possible Implications for Mechanisms of T Cell Depletion in HIV Disease. J Immunol. 2015;195:4096-105 pubmed 出版商
  225. Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias G, et al. Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation. Arthritis Rheumatol. 2016;68:449-61 pubmed 出版商
  226. Wei T, Zhang N, Guo Z, Chi F, Song Y, Zhu X. Wnt4 signaling is associated with the decrease of proliferation and increase of apoptosis during age-related thymic involution. Mol Med Rep. 2015;12:7568-76 pubmed 出版商
  227. Min S, Yan M, Kim S, Ravikumar S, Kwon S, Vanarsa K, et al. Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway. J Inflamm (Lond). 2015;12:53 pubmed 出版商
  228. Brasseit J, Althaus Steiner E, Faderl M, Dickgreber N, Saurer L, Genitsch V, et al. CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis. Mucosal Immunol. 2016;9:689-701 pubmed 出版商
  229. Martin Blondel G, Pignolet B, Tietz S, Yshii L, Gebauer C, Périnat T, et al. Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin. Eur J Immunol. 2015;45:3302-12 pubmed 出版商
  230. ZiÄ™tara N, Łyszkiewicz M, PuchaÅ‚ka J, Witzlau K, Reinhardt A, Förster R, et al. Multicongenic fate mapping quantification of dynamics of thymus colonization. J Exp Med. 2015;212:1589-601 pubmed 出版商
  231. Fiume G, Scialdone A, Albano F, Rossi A, Tuccillo F, Rea D, et al. Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice. Sci Rep. 2015;5:13864 pubmed 出版商
  232. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed 出版商
  233. Smith K, Filbey K, Reynolds L, Hewitson J, Harcus Y, Boon L, et al. Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths. Mucosal Immunol. 2016;9:428-43 pubmed 出版商
  234. Redpath S, Van Der Werf N, MacDonald A, Maizels R, Taylor M. Schistosoma mansoni Larvae Do Not Expand or Activate Foxp3+ Regulatory T Cells during Their Migratory Phase. Infect Immun. 2015;83:3881-9 pubmed 出版商
  235. Saulep Easton D, Vincent F, Quah P, Wei A, Ting S, Croce C, et al. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia. 2016;30:163-72 pubmed 出版商
  236. Ackerknecht M, Hauser M, Legler D, Stein J. In vivo TCR Signaling in CD4(+) T Cells Imprints a Cell-Intrinsic, Transient Low-Motility Pattern Independent of Chemokine Receptor Expression Levels, or Microtubular Network, Integrin, and Protein Kinase C Activity. Front Immunol. 2015;6:297 pubmed 出版商
  237. Chang C, Lin C, Lu C, Martel J, Ko Y, Ojcius D, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun. 2015;6:7489 pubmed 出版商
  238. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed 出版商
  239. Khan I, Perrard X, Brunner G, Lui H, Sparks L, Smith S, et al. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance. Int J Obes (Lond). 2015;39:1607-18 pubmed 出版商
  240. Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration. PLoS ONE. 2015;10:e0128094 pubmed 出版商
  241. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed 出版商
  242. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed 出版商
  243. Vuillefroy de Silly R, Ducimetière L, Yacoub Maroun C, Dietrich P, Derouazi M, Walker P. Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur J Immunol. 2015;45:2263-75 pubmed 出版商
  244. Becker P, Hervouet C, Mason G, KWON S, Klavinskis L. Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory. Vaccine. 2015;33:4691-8 pubmed 出版商
  245. Bouchery T, Kyle R, Camberis M, Shepherd A, Filbey K, Smith A, et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun. 2015;6:6970 pubmed 出版商
  246. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed 出版商
  247. Rouhani S, Eccles J, Riccardi P, Peske J, Tewalt E, Cohen J, et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun. 2015;6:6771 pubmed 出版商
  248. Lal G, Nakayama Y, Sethi A, Singh A, Burrell B, Kulkarni N, et al. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance. Transplantation. 2015;99:1817-28 pubmed 出版商
  249. Charlton J, Tsoukatou D, Mamalaki C, Chatzidakis I. Programmed death 1 regulates memory phenotype CD4 T cell accumulation, inhibits expansion of the effector memory phenotype subset and modulates production of effector cytokines. PLoS ONE. 2015;10:e0119200 pubmed 出版商
  250. Hu Lieskovan S, Mok S, Homet Moreno B, Tsoi J, Robert L, Goedert L, et al. Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma. Sci Transl Med. 2015;7:279ra41 pubmed 出版商
  251. Liu B, Lee J, Chen C, Hershey G, Wang Y. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J Immunol. 2015;194:3583-93 pubmed 出版商
  252. Van Den Ham K, Shio M, Rainone A, Fournier S, Krawczyk C, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451 pubmed 出版商
  253. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  254. Pratama A, Srivastava M, Williams N, Papa I, Lee S, Dinh X, et al. MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres. Nat Commun. 2015;6:6436 pubmed 出版商
  255. Wensveen F, Jelenčić V, Valentić S, Å estan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed 出版商
  256. Srivastava M, Duan G, Kershaw N, Athanasopoulos V, Yeo J, Ose T, et al. Roquin binds microRNA-146a and Argonaute2 to regulate microRNA homeostasis. Nat Commun. 2015;6:6253 pubmed 出版商
  257. Hsiao H, Hsu T, Liu W, Hsieh W, Chou T, Wu Y, et al. Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo. Nat Commun. 2015;6:6353 pubmed 出版商
  258. Stack G, Jones E, Marsden M, Stacey M, Snelgrove R, Lacaze P, et al. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathog. 2015;11:e1004641 pubmed 出版商
  259. Michelet X, Garg S, Wolf B, Tuli A, Ricciardi Castagnoli P, Brenner M. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b. J Immunol. 2015;194:2079-88 pubmed 出版商
  260. Triplett T, Tucker C, Triplett K, Alderman Z, Sun L, Ling L, et al. STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade. Cancer Immunol Res. 2015;3:526-35 pubmed 出版商
  261. Huang Y, Clarke F, Karimi M, Roy N, Williamson E, Okumura M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015;125:1019-32 pubmed 出版商
  262. Wirsdörfer F, Bangen J, Pastille E, Hansen W, Flohé S. Breaking the co-operation between bystander T-cells and natural killer cells prevents the development of immunosuppression after traumatic skeletal muscle injury in mice. Clin Sci (Lond). 2015;128:825-38 pubmed 出版商
  263. Zhang Y, Wu B, Metelli A, Thaxton J, Hong F, Rachidi S, et al. GP96 is a GARP chaperone and controls regulatory T cell functions. J Clin Invest. 2015;125:859-69 pubmed 出版商
  264. Bergot A, Monnet N, Le Tran S, Mittal D, Al Kouba J, Steptoe R, et al. HPV16 E7 expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions. Immunol Cell Biol. 2015;93:540-7 pubmed 出版商
  265. Glatigny S, Duhen R, Arbelaez C, Kumari S, Bettelli E. Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4. Sci Rep. 2015;5:7834 pubmed 出版商
  266. Clouthier D, Zhou A, Wortzman M, Luft O, Levy G, Watts T. GITR intrinsically sustains early type 1 and late follicular helper CD4 T cell accumulation to control a chronic viral infection. PLoS Pathog. 2015;11:e1004517 pubmed 出版商
  267. Singh K, Hjort M, Thorvaldson L, Sandler S. Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice. Sci Rep. 2015;5:7767 pubmed 出版商
  268. Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015;25:208-24 pubmed 出版商
  269. Teixeira L, Moreira J, Melo J, Bezerra F, Marques R, Ferreirinha P, et al. Immune response in the adipose tissue of lean mice infected with the protozoan parasite Neospora caninum. Immunology. 2015;145:242-57 pubmed 出版商
  270. Djukic M, Sostmann N, Bertsch T, Mecke M, Nessler S, Manig A, et al. Vitamin D deficiency decreases survival of bacterial meningoencephalitis in mice. J Neuroinflammation. 2015;12:208 pubmed 出版商
  271. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed 出版商
  272. Baeyens A, Saadoun D, Billiard F, Rouers A, Grégoire S, Zaragoza B, et al. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context. J Immunol. 2015;194:999-1010 pubmed 出版商
  273. Krishnamoorthy N, Burkett P, Dalli J, Abdulnour R, Colas R, Ramon S, et al. Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol. 2015;194:863-7 pubmed 出版商
  274. Su X, Zhang L, Ye J, Yang L, Li Y, Wang Y. Bone marrow mesenchymal stem cells suppress ascitogenous hepatoma progression in BALB/c mouse through reducing myeloid-derived suppressor cells. Biomed Mater Eng. 2015;25:167-77 pubmed 出版商
  275. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed 出版商
  276. Li Q, Zou J, Wang M, Ding X, Chepelev I, Zhou X, et al. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation. Nat Commun. 2014;5:5780 pubmed 出版商
  277. Yuan X, Dee M, Altman N, Malek T. IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa. J Immunol. 2015;194:1334-46 pubmed 出版商
  278. Böhm L, Maxeiner J, Meyer Martin H, Reuter S, Finotto S, Klein M, et al. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma. J Immunol. 2015;194:887-97 pubmed 出版商
  279. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed 出版商
  280. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed 出版商
  281. Naik A, Hawwari A, Krangel M. Specification of Vδ and Vα usage by Tcra/Tcrd locus V gene segment promoters. J Immunol. 2015;194:790-4 pubmed 出版商
  282. Rutz S, Kayagaki N, Phung Q, Eidenschenk C, Noubade R, Wang X, et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature. 2015;518:417-21 pubmed 出版商
  283. Raker V, Stein J, Montermann E, Maxeiner J, Taube C, Reske Kunz A, et al. Regulation of IgE production and airway reactivity by CD4⁻CD8⁻ regulatory T cells. Immunobiology. 2015;220:490-9 pubmed 出版商
  284. Lees J, Duffy S, Perera C, Moalem Taylor G. Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury. Cytokine. 2015;71:207-14 pubmed 出版商
  285. Guo X, Tanaka Y, Kondo M. Thymic precursors of TCRαβ(+)CD8αα(+) intraepithelial lymphocytes are negative for CD103. Immunol Lett. 2015;163:40-8 pubmed 出版商
  286. Peters A, Burkett P, Sobel R, Buckley C, Watson S, Bettelli E, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125:129-40 pubmed 出版商
  287. Baptista A, Roozendaal R, Reijmers R, Koning J, Unger W, Greuter M, et al. Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation. elife. 2014;3: pubmed 出版商
  288. Uchiyama M, Jin X, Yin E, Shimokawa T, Niimi M. Treadmill exercise induces murine cardiac allograft survival and generates regulatory T cell. Transpl Int. 2015;28:352-62 pubmed 出版商
  289. Patel P, Julien J, Kriz J. Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12:217-33 pubmed 出版商
  290. Kern J, Drutel R, Leanhart S, Bogacz M, Pacholczyk R. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome. PLoS ONE. 2014;9:e112467 pubmed 出版商
  291. McKinstry K, Strutt T, Bautista B, Zhang W, Kuang Y, Cooper A, et al. Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat Commun. 2014;5:5377 pubmed 出版商
  292. Mouchacca P, Chasson L, Frick M, Foray C, Schmitt Verhulst A, Boyer C. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes. Immunology. 2015;145:24-33 pubmed 出版商
  293. Dang V, Tanabe K, Tanaka Y, Tokumoto N, Misumi T, Saeki Y, et al. Fasting enhances TRAIL-mediated liver natural killer cell activity via HSP70 upregulation. PLoS ONE. 2014;9:e110748 pubmed 出版商
  294. Thauland T, Koguchi Y, Dustin M, Parker D. CD28-CD80 interactions control regulatory T cell motility and immunological synapse formation. J Immunol. 2014;193:5894-903 pubmed 出版商
  295. Velardi E, Tsai J, Holland A, Wertheimer T, Yu V, Zakrzewski J, et al. Sex steroid blockade enhances thymopoiesis by modulating Notch signaling. J Exp Med. 2014;211:2341-9 pubmed 出版商
  296. Xie L, Choudhury G, Winters A, Yang S, Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45:180-91 pubmed 出版商
  297. Maneva Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1. PLoS ONE. 2014;9:e107213 pubmed 出版商
  298. Tassi I, Claudio E, Wang H, Tang W, Ha H, Saret S, et al. The NF-κB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity. J Immunol. 2014;193:4303-11 pubmed 出版商
  299. Chen M, Chen Y, Wu M, Yu G, Lin W, Tan T, et al. PP4 is essential for germinal center formation and class switch recombination in mice. PLoS ONE. 2014;9:e107505 pubmed 出版商
  300. Naik E, Webster J, DeVoss J, Liu J, Suriben R, Dixit V. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med. 2014;211:1947-55 pubmed 出版商
  301. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed 出版商
  302. Wu C, He S, Peng Y, Kushwaha K, Lin J, Dong J, et al. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice. J Mol Cell Cardiol. 2014;76:33-45 pubmed 出版商
  303. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed 出版商
  304. Kim K, Skora A, Li Z, Liu Q, Tam A, Blosser R, et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells. Proc Natl Acad Sci U S A. 2014;111:11774-9 pubmed 出版商
  305. Céspedes P, Bueno S, Ramírez B, Gómez R, Riquelme S, Palavecino C, et al. Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci U S A. 2014;111:E3214-23 pubmed 出版商
  306. Johannesson B, Sattler S, Semenova E, Pastore S, Kennedy Lydon T, Sampson R, et al. Insulin-like growth factor-1 induces regulatory T cell-mediated suppression of allergic contact dermatitis in mice. Dis Model Mech. 2014;7:977-85 pubmed 出版商
  307. Reeh K, Cardenas K, Bain V, Liu Z, LAURENT M, Manley N, et al. Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis. Development. 2014;141:2950-8 pubmed 出版商
  308. Berod L, Stüve P, Varela F, Behrends J, Swallow M, Kruse F, et al. Rapid rebound of the Treg compartment in DEREG mice limits the impact of Treg depletion on mycobacterial burden, but prevents autoimmunity. PLoS ONE. 2014;9:e102804 pubmed 出版商
  309. Madireddi S, Eun S, Lee S, Nemčovičová I, Mehta A, Zajonc D, et al. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. J Exp Med. 2014;211:1433-48 pubmed 出版商
  310. Au Yeung B, Melichar H, Ross J, Cheng D, Zikherman J, Shokat K, et al. Quantitative and temporal requirements revealed for Zap70 catalytic activity during T cell development. Nat Immunol. 2014;15:687-94 pubmed 出版商
  311. Geem D, Medina Contreras O, McBride M, Newberry R, Koni P, Denning T. Specific microbiota-induced intestinal Th17 differentiation requires MHC class II but not GALT and mesenteric lymph nodes. J Immunol. 2014;193:431-8 pubmed 出版商
  312. Xie L, Sun F, Wang J, Mao X, Xie L, Yang S, et al. mTOR signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia. J Immunol. 2014;192:6009-19 pubmed 出版商
  313. Weber G, Chousterman B, Hilgendorf I, Robbins C, Theurl I, Gerhardt L, et al. Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J Exp Med. 2014;211:1243-56 pubmed 出版商
  314. Kitagawa K, Shibata K, Matsumoto A, Matsumoto M, Ohhata T, Nakayama K, et al. Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Mol Cell Biol. 2014;34:2732-44 pubmed
  315. Zhang Y, Yan W, Mathew E, Bednar F, Wan S, Collins M, et al. CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice. Cancer Immunol Res. 2014;2:423-35 pubmed 出版商
  316. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed 出版商
  317. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed 出版商
  318. Oetjen S, Mahlke C, Hermans Borgmeyer I, Hermey G. Spatiotemporal expression analysis of the growth factor receptor SorCS3. J Comp Neurol. 2014;522:3386-402 pubmed 出版商
  319. Cochain C, Chaudhari S, Koch M, Wiendl H, Eckstein H, Zernecke A. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS ONE. 2014;9:e93280 pubmed 出版商
  320. Keswani T, Bhattacharyya A. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii. Exp Parasitol. 2014;141:82-92 pubmed 出版商
  321. León B, Bradley J, Lund F, Randall T, Ballesteros Tato A. FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability. Nat Commun. 2014;5:3495 pubmed 出版商
  322. Fu H, Kishore M, Gittens B, Wang G, Coe D, Komarowska I, et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun. 2014;5:3436 pubmed 出版商
  323. Vanoaica L, Richman L, Jaworski M, Darshan D, Luther S, Kühn L. Conditional deletion of ferritin h in mice reduces B and T lymphocyte populations. PLoS ONE. 2014;9:e89270 pubmed 出版商
  324. Lee J, Walsh M, Hoehn K, James D, Wherry E, Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol. 2014;192:3190-9 pubmed 出版商
  325. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed 出版商
  326. Joedicke J, Dietze K, Zelinskyy G, Dittmer U. The phenotype and activation status of regulatory T cells during Friend retrovirus infection. Virol Sin. 2014;29:48-60 pubmed 出版商
  327. Xia S, Wei J, Wang J, Sun H, Zheng W, Li Y, et al. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. J Leukoc Biol. 2014;95:733-742 pubmed
  328. Xiong H, Maraver A, Latkowski J, Henderson T, Schlessinger K, Ding Y, et al. Characterization of two distinct lymphoproliferative diseases caused by ectopic expression of the Notch ligand DLL4 on T cells. PLoS ONE. 2013;8:e84841 pubmed 出版商
  329. Hu Y, Xiao H, Shi T, Oppenheim J, Chen X. Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4? Foxp3? regulatory T cells. Immunology. 2014;142:193-201 pubmed 出版商
  330. Saligrama N, Case L, Krementsov D, Teuscher C. Histamine H₂ receptor signaling × environment interactions determine susceptibility to experimental allergic encephalomyelitis. FASEB J. 2014;28:1898-909 pubmed 出版商
  331. Kim E, Gasper D, Lee S, Plisch E, Svaren J, Suresh M. Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice. J Immunol. 2014;192:985-95 pubmed 出版商
  332. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed 出版商
  333. Salem H, Trojanowski B, Fiedler K, Maier H, Schirmbeck R, Wagner M, et al. Long-term IKK2/NF-?B signaling in pancreatic ?-cells induces immune-mediated diabetes. Diabetes. 2014;63:960-75 pubmed 出版商
  334. Chan I, Jain R, Tessmer M, Gorman D, Mangadu R, Sathe M, et al. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol. 2014;7:842-56 pubmed 出版商
  335. Chopra M, Lang I, Salzmann S, Pachel C, Kraus S, Bäuerlein C, et al. Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1. PLoS ONE. 2013;8:e75737 pubmed 出版商
  336. Qiao G, Zhao Y, Li Z, Tang P, Langdon W, Yang T, et al. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells. J Immunol. 2013;191:632-9 pubmed 出版商
  337. Redecke V, Wu R, Zhou J, Finkelstein D, Chaturvedi V, High A, et al. Hematopoietic progenitor cell lines with myeloid and lymphoid potential. Nat Methods. 2013;10:795-803 pubmed 出版商
  338. Toker A, Engelbert D, Garg G, Polansky J, Floess S, Miyao T, et al. Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus. J Immunol. 2013;190:3180-8 pubmed 出版商
  339. Redpath S, Van Der Werf N, Cervera A, MacDonald A, Gray D, Maizels R, et al. ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection. Eur J Immunol. 2013;43:705-15 pubmed 出版商
  340. Kipari T, Hadoke P, Iqbal J, Man T, Miller E, Coutinho A, et al. 11?-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis. FASEB J. 2013;27:1519-31 pubmed 出版商
  341. Yassai M, Cooley B, Gorski J. Developmental dynamics of post-selection thymic DN iNKT. PLoS ONE. 2012;7:e43509 pubmed 出版商
  342. Golias J, Schwarzer M, Wallner M, Kverka M, Kozakova H, Srůtková D, et al. Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy. PLoS ONE. 2012;7:e37156 pubmed 出版商
  343. Uchiyama M, Jin X, Zhang Q, Hirai T, Amano A, Bashuda H, et al. Auditory stimulation of opera music induced prolongation of murine cardiac allograft survival and maintained generation of regulatory CD4+CD25+ cells. J Cardiothorac Surg. 2012;7:26 pubmed 出版商
  344. Oestreich K, Mohn S, Weinmann A. Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile. Nat Immunol. 2012;13:405-11 pubmed 出版商
  345. Stone J, McMillan R, Skaar D, Bradshaw J, Jirtle R, Sikes M. DNA double-strand breaks relieve USF-mediated repression of D?2 germline transcription in developing thymocytes. J Immunol. 2012;188:2266-75 pubmed 出版商
  346. Wang R, Xie H, Huang Z, Ma J, Fang X, Ding Y, et al. T cell factor 1 regulates thymocyte survival via a RORγt-dependent pathway. J Immunol. 2011;187:5964-73 pubmed 出版商
  347. Tousif S, Singh Y, Prasad D, Sharma P, Van Kaer L, Das G. T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection. PLoS ONE. 2011;6:e19864 pubmed 出版商
  348. Goldstein J, Balderas R, Marodon G. Continuous activation of the CD122/STAT-5 signaling pathway during selection of antigen-specific regulatory T cells in the murine thymus. PLoS ONE. 2011;6:e19038 pubmed 出版商
  349. Mandal M, Marzouk A, Donnelly R, Ponzio N. Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav Immun. 2011;25:863-71 pubmed 出版商
  350. Echeverry A, Saijo S, Schesser K, Adkins B. Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonates. Infect Immun. 2010;78:3595-608 pubmed 出版商
  351. Barwig C, Raker V, Montermann E, Grabbe S, Reske Kunz A, Sudowe S. Antigen dose-dependent suppression of murine IgE responses is mediated by CD4(-)CD8(-) double-negative T cells. Clin Exp Allergy. 2010;40:891-901 pubmed 出版商
  352. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed 出版商
  353. Imada M, Masuda K, Satoh R, Ito Y, Goto Y, Matsuoka T, et al. Ectopically expressed PIR-B on T cells constitutively binds to MHC class I and attenuates T helper type 1 responses. Int Immunol. 2009;21:1151-61 pubmed 出版商
  354. Schartner J, Singh A, Dahlberg P, Nettenstrom L, Seroogy C. Recurrent superantigen exposure in vivo leads to highly suppressive CD4+CD25+ and CD4+CD25- T cells with anergic and suppressive genetic signatures. Clin Exp Immunol. 2009;155:348-56 pubmed 出版商
  355. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, et al. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res. 2008;18:846-57 pubmed 出版商
  356. Yates J, Whittington A, Mitchell P, Lechler R, Lightstone L, Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol. 2008;153:44-55 pubmed 出版商
  357. Robertson S, Messer R, Carmody A, Mittler R, Burlak C, Hasenkrug K. CD137 costimulation of CD8+ T cells confers resistance to suppression by virus-induced regulatory T cells. J Immunol. 2008;180:5267-74 pubmed
  358. Park S, Han Y, Aleyas A, George J, Yoon H, Lee J, et al. Low-dose antigen-experienced CD4+ T cells display reduced clonal expansion but facilitate an effective memory pool in response to secondary exposure. Immunology. 2008;123:426-37 pubmed
  359. Walsh C, Smith P, Fallon P. Role for CTLA-4 but not CD25+ T cells during Schistosoma mansoni infection of mice. Parasite Immunol. 2007;29:293-308 pubmed
  360. Stephens G, Andersson J, Shevach E. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J Immunol. 2007;178:6901-11 pubmed
  361. Huang B, Zhao J, Shen S, Li H, He K, Shen G, et al. Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res. 2007;67:4346-52 pubmed
  362. Bros M, Jährling F, Renzing A, Wiechmann N, Dang N, Sutter A, et al. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Blood. 2007;109:3820-9 pubmed
  363. Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A. 2007;81:652-62 pubmed
  364. Hofmann M, Brinkmann V, Zerwes H. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int Immunopharmacol. 2006;6:1902-10 pubmed
  365. Taylor P, Tsoni S, Willment J, Dennehy K, Rosas M, Findon H, et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol. 2007;8:31-8 pubmed
  366. Chen B, Deoliveira D, Cui X, Le N, Son J, Whitesides J, et al. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood. 2007;109:3115-23 pubmed
  367. Kotner J, Tarleton R. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect Immun. 2007;75:861-9 pubmed
  368. Yaddanapudi K, Palacios G, Towner J, Chen I, Sariol C, Nichol S, et al. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006;20:2519-30 pubmed 出版商
  369. Cassan C, Piaggio E, Zappulla J, Mars L, Couturier N, Bucciarelli F, et al. Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells. J Immunol. 2006;177:1552-60 pubmed
  370. Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol. 2006;7:819-26 pubmed
  371. Leithäuser F, Meinhardt Krajina T, Fink K, Wotschke B, Moller P, Reimann J. Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis. Am J Pathol. 2006;168:1898-909 pubmed
  372. Hale J, Boursalian T, Turk G, Fink P. Thymic output in aged mice. Proc Natl Acad Sci U S A. 2006;103:8447-52 pubmed
  373. Sfondrini L, Rossini A, Besusso D, Merlo A, Tagliabue E, Menard S, et al. Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer. J Immunol. 2006;176:6624-30 pubmed
  374. Vanasek T, Nandiwada S, Jenkins M, Mueller D. CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia. J Immunol. 2006;176:5880-9 pubmed
  375. Hofmann M, Zerwes H. Identification of organ-specific T cell populations by analysis of multiparameter flow cytometry data using DNA-chip analysis software. Cytometry A. 2006;69:533-40 pubmed
  376. Robertson S, Messer R, Carmody A, Hasenkrug K. In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells. J Immunol. 2006;176:3342-9 pubmed
  377. Miglio G, Varsaldi F, Lombardi G. Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation. Biochem Biophys Res Commun. 2005;338:1875-83 pubmed
  378. Krieg C, Han P, Stone R, Goularte O, Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol. 2005;175:6420-7 pubmed
  379. Lu M, Tayu R, Ikawa T, Masuda K, Matsumoto I, Mugishima H, et al. The earliest thymic progenitors in adults are restricted to T, NK, and dendritic cell lineage and have a potential to form more diverse TCRbeta chains than fetal progenitors. J Immunol. 2005;175:5848-56 pubmed
  380. Garcia Ojeda M, Dejbakhsh Jones S, Chatterjea Matthes D, Mukhopadhyay A, BitMansour A, Weissman I, et al. Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus. J Immunol. 2005;175:4363-73 pubmed
  381. Sangaletti S, Gioiosa L, Guiducci C, Rotta G, Rescigno M, Stoppacciaro A, et al. Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice. J Cell Sci. 2005;118:3685-94 pubmed
  382. Gray P, Arimilli S, Palmer E, Parks G, Alexander Miller M. Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract. J Virol. 2005;79:3339-49 pubmed
  383. van Santen H, Benoist C, Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med. 2004;200:1221-30 pubmed
  384. Mangan N, Fallon R, Smith P, Van Rooijen N, McKenzie A, Fallon P. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol. 2004;173:6346-56 pubmed
  385. Hequet O, Vocanson M, Saint Mezard P, Kaiserlian D, Nicolas J, Berard F. CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease. Am J Transplant. 2004;4:872-8 pubmed
  386. Wang Y, Lobigs M, Lee E, Mullbacher A. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol. 2003;77:13323-34 pubmed
  387. Hogg K, Kumkate S, Mountford A. IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine. Int Immunol. 2003;15:1451-9 pubmed
  388. Maris C, Miller J, Altman J, Jacob J. A transgenic mouse model genetically tags all activated CD8 T cells. J Immunol. 2003;171:2393-401 pubmed
  389. Kawamoto H, Ohmura K, Fujimoto S, Lu M, Ikawa T, Katsura Y. Extensive proliferation of T cell lineage-restricted progenitors in the thymus: an essential process for clonal expression of diverse T cell receptor beta chains. Eur J Immunol. 2003;33:606-15 pubmed
  390. Otten L, Tacchini Cottier F, Lohoff M, Annunziato F, Cosmi L, Scarpellino L, et al. Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes. J Immunol. 2003;170:1150-7 pubmed
  391. Cabatingan M, Schmidt M, Sen R, Woodland R. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J Immunol. 2002;169:6795-805 pubmed
  392. Angulo I, Jiménez Díaz M, García Bustos J, Gargallo D, de las Heras F, Muñoz Fernández M, et al. Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production. Cell Immunol. 2002;218:46-58 pubmed
  393. Goñi O, Alcaide P, Fresno M. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells. Int Immunol. 2002;14:1125-34 pubmed
  394. Wu T, Lee J, Lai Y, Hsu J, Tsai C, Lee Y, et al. Reduced expression of Bcl-2 in CD8+ T cells deficient in the IL-15 receptor alpha-chain. J Immunol. 2002;168:705-12 pubmed
  395. Saio M, Radoja S, Marino M, Frey A. Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J Immunol. 2001;167:5583-93 pubmed
  396. Ng W, Duggan P, Ponchel F, Matarese G, Lombardi G, Edwards A, et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood. 2001;98:2736-44 pubmed
  397. Kovalev G, Franklin D, Coffield V, Xiong Y, Su L. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation. J Immunol. 2001;167:3285-92 pubmed
  398. Campbell I, O DONNELL K, Lawlor K, Wicks I. Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J Clin Invest. 2001;107:1519-27 pubmed
  399. Radoja S, Saio M, Frey A. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol. 2001;166:6074-83 pubmed
  400. Van Stipdonk M, Lemmens E, Schoenberger S. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol. 2001;2:423-9 pubmed
  401. Agrawal S, Marquet J, Plumas J, Rouard H, Delfau Larue M, Gaulard P, et al. Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol. 2001;13:441-50 pubmed
  402. Attinger A, MacDonald H, Acha Orbea H. Lymphoid environment limits superantigen and antigen-induced T cell proliferation at high precursor frequency. Eur J Immunol. 2001;31:884-93 pubmed
  403. Izeradjene K, Revillard J, Genestier L. Inhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells. Int Immunol. 2001;13:85-93 pubmed
  404. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  405. Kang J, Coles M, Raulet D. Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. J Exp Med. 1999;190:973-82 pubmed
  406. Zerrahn J, Volkmann A, Coles M, Held W, Lemonnier F, Raulet D. Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proc Natl Acad Sci U S A. 1999;96:11470-5 pubmed
  407. Inaba M, Kurasawa K, Mamura M, Kumano K, Saito Y, Iwamoto I. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J Immunol. 1999;163:1315-20 pubmed
  408. Payne K, Medina K, Kincade P. Loss of c-kit accompanies B-lineage commitment and acquisition of CD45R by most murine B-lymphocyte precursors. Blood. 1999;94:713-23 pubmed
  409. Clark L, Appleby M, Brunkow M, Wilkinson J, Ziegler S, Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol. 1999;162:2546-54 pubmed
  410. Spiekermann G, Nagler Anderson C. Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J Immunol. 1998;161:5825-31 pubmed
  411. Vincent M, Roessner K, Sellati T, Huston C, Sigal L, Behar S, et al. Lyme arthritis synovial gamma delta T cells respond to Borrelia burgdorferi lipoproteins and lipidated hexapeptides. J Immunol. 1998;161:5762-71 pubmed
  412. Liu L, Rich B, Inobe J, Chen W, Weiner H. Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4. Int Immunol. 1998;10:1017-26 pubmed
  413. van Meerwijk J, Marguerat S, MacDonald H. Homeostasis limits the development of mature CD8+ but not CD4+ thymocytes. J Immunol. 1998;160:2730-4 pubmed
  414. Aiba Y, Ogawa M. Development of natural killer cells, B lymphocytes, macrophages, and mast cells from single hematopoietic progenitors in culture of murine fetal liver cells. Blood. 1997;90:3923-30 pubmed
  415. Aiba Y, Hirayama F, Ogawa M. Clonal proliferation and cytokine requirement of murine progenitors for natural killer cells. Blood. 1997;89:4005-12 pubmed
  416. Lin K, Abraham K. Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway. Int Immunol. 1997;9:291-306 pubmed
  417. Lowenthal J, Zubler R, Nabholz M, MacDonald H. Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature. 1985;315:669-72 pubmed
  418. Ceredig R, Lowenthal J, Nabholz M, MacDonald H. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature. 1985;314:98-100 pubmed